![](/imagelib/sitebuilder/layout/spacer.gif) |
![](/imagelib/sitebuilder/layout/spacer.gif) |
![](/imagelib/sitebuilder/layout/spacer.gif) |
|
Diseases of The Western Diet and role of fructose
|
|
![](/imagelib/sitebuilder/layout/spacer.gif) |
Abbreviations: AD Alzheimer’s
disease/dementia ADA
American Diabetic Association ATP
adenosine triphosphate
BMJ British Medical
Journal
CVD cardiovascular
disease CAWD conditions associated with the high sugar-fructose Western
diet CME continuing
medical education HSD
high sugar diet IR
insulin resistance/resistant KOL
key opinion leader, a thought leader LSP low-sugar
populations/diet MeS metabolic syndrome
NAFLD non-alcoholic fatty liver disease NEJM
New England Journal of Medicine RAGE receptors
for advanced glycation
end-products ROS reactive
oxygen species t1d type 1 diabetes
t2d
type-two diabetes TOFI thin on outside fat on inside Wiki
Wikipedia
Mystery:
why peoples
who eat life-long low-sugar (fructose) diet including their elderly have very
low rates of the conditions associated with the Western diet (CAWD)? Their diets
vary widely thus conflicting with
the standard list of major causes: refined carbs, high protein/meat,
high fat, high saturated
fats, and sedentary lifestyle; but not sugar. Where ever those
LSPs switch to the Western diet, depending on amount of sugar, CAWD become over
90% of the causes of death and morbidity, a much different list is for the
LSP. A sophisticated analysis of a decade of data on sugar consumption for
over 50 countries has been analyzed and it has firmly established the high-sugar
diet is the cause for CAWD— refined carbs have a much weaker association.
This leads to
the second
question and answer: why is it that
those with type 2 diabetes (t2d) have the same conditions of those on a high
sugar diet (HSD), the only difference being the rate? Answer, both are
insulin resistance, differing
only in degrees. Elevated glucose is not
the cause but a sign—see Relying
on the work of Joseph R. Kraft MD,
there are 4 patterns of IR, the 4th has progressed to t2d due to a fatty-inflamed
pancreas which causes a decline in insulin production. By using IR as its key
marker, it becomes
clear that the risk of the comorbidities is dependent upon the degree of IR,
and IR is unknown among LSP thus they don’t have CAWD! Using IR as the
measure of risk, I would
estimate that about 95%, of Americans are at significant risk for CAWD. With
IR as the marker for risk of CAWD, a
light is shine on the chaos created by facts and theories. What
evolution is to nature, IR is to CAWD: they illuminate their spheres.
What follows
is based on
publish research on the pathogenic mechanism caused by fructose that affects
every cell in the body. As Prof. Robert Lustig says,
“Fructose is ethanol without the buzz.” While some of you have
heard that fructose is
safe for diabetic because it doesn’t raise insulin, and that when managed with
drugs sugar and refined carbs are safe according to the American Diabetic
Association. The American Heart
Association approved for a fee Heart Healthy sticker on high sugar foods
including fruit juices and sugar coated cereals. Now following the World Health
Organizations
change in recommendations, sugar is to be limited to 6 teaspoons a day for
women and 9 for men (24 and 36 grams) all sources. This message has been buried
is billions of
dollars of advertising promoting high sugar manufactured foods. Also buried
is the questions about CAWD, the
role of sugar, and the scientific evidence explain why fructose (on half of the
sugar molecule) is toxic to some at above 20 grams a day, and nearly all at
above 100 grams a day.
Listen and attend
my
beloved (a phrase repeatedly used by Rudyard Kipling) and I shall the store of
the high fructose—glucose is merely a bit actor.
Terms
not in common usage
though of importance
TOFI: thin on the outside,
fat on the inside. This refers to
abdominal fat which is associated with MeS,
NAFLD, IR, and CAWD. I hold
that it isn’t abdominal fat, but the
subclass of fatty liver that is causal.
Fatty liver is strongly associated with IR and the consequences of excessive
fructose damaging biological
systems. IR and fructose explain
why those people who ate a western diet,
even after changing their diet decades before, that most of them are still at
risks for CAWD.
Diabesity: ”used to refer to a form of diabetes
that
typically develops in later life and is associated with being obese.” Google --derived from the words diabetes & obesity.
Glycation/fructosylation:
glycation is the random attachment
of a sugar to a protein. It is often
used to refer to glucose bonding, but can include fructose and other common
mono-saccharides, while fructosylation refers
to the action of fructose.
Bad pharma, tobacco
ethics and
tobaccos science,
refers to an industry that puts profits before people, and marketing dressed as
science, see Appendix ???
As an
aide, I highly recommend that you print the outline page--LINK
Sucrose, a disaccharide of glucose and
fructose. Note the 5 member ring of fructose, the angle
of the oxygen member of the ring is under greater stress because of it angle than
the oxygen in the 6 member glucose ring, and this entails that the frequency of
being in the open form (instead of ring) is significant greater for
fructose. In this open form, fructose to
a greater extent than glucose react with a several amino acids on proteins in a
process called either fructosylation
or glycation. Various source rate
fructose as 7 to 10 more
reactive than glucose. Since 95%
of fructose is metabolized in the
liver, and it is delay while glucose is metabolized first, fructose is a net 20
times more reactive than glucose in the liver.
Listen and attend
my
beloved (a phrase repeatedly used by Rudyard Kipling) and I shall tell the story of
excess fructose—glucose is merely a bit actor.
|
|
![](/imagelib/sitebuilder/layout/spacer.gif) |
Evidence for Conditions Associated with
the Western Diet (CAWD) -- an introductory
ramble
a. Conditions linked to RAGE
[receptors for advanced glycation end products]. They all are very rare
among those on LSP; thus they are all
CAWD! This paper explains that it isn’t caused by
glucose by the 10 times more reactive fructose which goes directly to the liver
the only major tissue that can metabolize fructose, and which those on a
western diet consume more than cellular receptors can repair, thereby damaging
the liver to cause IR and other abnormalities that increase the risk for CAWD.
Alzheimer's disease Arthritis[14] Atherosclerosis Congestive heart failure Diabetic neuropathy Diabetic nephropathy Diabetic retinopathy Myocardial infarction [and
other ischemic events including strokes] Peripheral vascular disease
[includes coronary heart
disease] Psoriasis Rheumatoid Arthritis[15] Takayasu's arteritis[16 Wikipedia (12/17) All
of these are linked to CAWD, others have added
cancer, insulin resistance, non-alcoholic fatty
liver
disease, dysregulation of the weight control system (weight gain), type-2
diabetes, most types of dementia, gout, acne, hypertension, strokes, varicose
veins, palsy, macular degeneration, inflammatory bowel diseases, appendicitis,
osteoarthritis and all other conditions not named above which are associated
with t2d. Compared to the low
sugar populations (LSP), their rates are below 1/20th the rate the
rate of those on the western high sugar diet, and that includes cancer and CVD which were unknown among
aboriginal Negroes, the Kitavans, and others before the introduction of highly
portable sugar and refined grains. Population evidence of
a low sugar diet--LINK b.
Hyperglycemia, saturated fats, and cholesterol--the scapegoats: sadly to say, industries intrusion
has most
researchers looking under the wrong tree for what has gone wrong, because pharma
profits from illness and the food manufacturers profits from replacing whole
foods with manufacture foods, which are
high in sugars to reach the bliss point.[1] What we have is a situation in which in a
fire-pump truck has a crew of 2 (fructose and glucose) known as the sucrose
brothers, and one of them, fructose, is a pyromaniac, so instead they (pharma
and food manufactures) pay the media, scientist for hire, politicians, and the
medical and dietary associations to blame saturated fats and cholesterol for
the fires of CAWD. This “villain”
fructose, along with his
brother sucrose, is still in the fire station watching the news about the conflagration
they started. The building material
cholesterol and
saturated fats used to repair cell build cell walls, make hormones, insulate
nerves, fuel for ATP, etc. is charged with the fires. The repair workers, physicians
and dieticians,
are monitoring blood cholesterol, triglycerides, glucose, and glycated
hemoglobin (HbA1c), and pharma pushes drugs that block the production of
cholesterol and for diabetics, drugs that lower blood glucose by stuffing more
into overloaded cells. The industries
are in bed with the sucrose brothers along with those whom they influence. What
follows are the mechanisms on fructose that
causes IR, MeS, t2d, and CAWD. Obviously, prevention of the fire is to reduce
sugar; and in Section VII is on how to reverse NAFLD, IR and t2d by diet, and
to allow the cells toasted in the fire to heal naturally. c. Basic explanation: Fructose
is one-half of the disaccharide sucrose--the other half is glucose. Fructose is
quite different than sucrose because its pentose ring is less stable than
glucose’s hexose ring: fructose is a net
20 more reactive than glucose in
the liver where fructose is metabolized.
On a high sugar diet there is a dual
assault that damages the liver by accumulation of excess fat through de
novo lipogenesis within the hepatocytes and stored in the liver’s adipocytes and
by fructosylation.[2] This assault of excessive storage of fat in
the hepatocytes and the damage done to proteins by fructose attaching to
proteins in the hepatocytes (fructosylation) overwhelms the liver’s cellular
repair systems. With the damage to the
hepatocytes mitochondria (visible as deformation) which results in the
underproduction of ATP and because
of the underproduction of ATP the energy molecule, there is
reduction in the rate of cellular repair systems such as superoxide dismutase,
MTOR, and others, and this results in the lower rate of replacement of
collagen, increased sensitivity to the damage cause by uric acid, upsets the
hormonal regulatory system that control appetite, metabolism, and from
continued fructosylation to name the major contributors to CAWD. This combination affects the hepatocytes ability
to metabolize glucose and convert it to glycogen, thus the hepatocytes to avoid
excessive glucose with its increased osmotic pressure become resistant to the
uptake of more glucose. In the liver
insulin’s the transport of serum glucose is down regulated; this is known as insulin
resistance (in the liver).
Eventually with the reduced liver function because of the damage to the
hepatocytes for reasons needing further research the other tissues become resistant,
especially the
myocytes and the adipocytes (the major users of glucose, along with the brain). Excess
fructose is part of a vicious cycle, on a high carb diet it lipogenesis is
increased, because the glucose has supplied sufficient ATP, so it is conversion
to fat is increased compared to a meal lower in carbs. Also a product of fructose
metabolism is uric
acid. Fructose this is both very
lipogenic and is a major source for the sharp uric acid microcrystals. For now
remember that long-term excess
fructose is comparable to excess long-term ethanol drinking, but worse. Worse
because
downstream from liver damage and IR
are further changes including the under production of collagens, cellular ROS,
kidney damage, endothelial dysfunction, glycation and fructosylation of proteins,
hypoxia, defective mitochondria[3], reduced
production of ATP which reduces the rates of cellular repair systems,
and this increases the amount of other compounds (such as beta amyloid) that
are pathogenic, increased sensitivity to uric acid, lipophilia (weight gain),
fatty liver and pancreas, leptin and insulin resistance, and t2d, MeS and thereby CAWD.
On top of this it lights up the dopaminergic pathway (seen under
imaging) in the addiction center, the nucleus accumbens, to causes sugar
addiction. Homo sapiens are poisoned by
their high fructose western diet. d. Sources for
material on CAWD, LSP, and fructose: The best short source
summarizing the evidence for CAWD
that I have found is in chapter 5, Good Calories,
Bad Calories (2002)
by the highly rated science writer Gary Taubes and his The Case Against Sugar
(2016) chapter 11—see LINK. Hugh Trowell
and Denis Burkitt’s, Western Diseases Their Emergence
and
Prevention, 1981 is the most complete source: 21 contributors present articles on the
health conditions of peoples in different regions around the world who are on a
traditional diet—see link. In the journal
article The Western Diet and Lifestyle
and Diseases of Civilization[4]
are measurements of blood pressure, fasting insulin, fasting leptin, and oxygen
consumption for the Kitavans whom Staffan Lindeberg studied and compared to healthy
Swedes—see link. Other peoples
are included in at that link by
me. However, Trowell, Burkitt and
Lindeberg’s beliefs as to causes for CAWD
suffer from swallowing the current cornucopia of causes—Lindeberg promotes the
paleo diet as fix, and Trowell and Burkitt, low fat, cholesterol, low salt, and
high fiber. Sugar was singled out as
starting point for over a century, but it was based on the observation that there
are conditions of the rich. Observations
don’t prove causation, and books such as Low
Blood Sugar and You, Carlton
Frederick, Ph.D., 1969, lacked science. Often
sugar was grouped with refined carbs and still is ( I reject the charge against
glucose, see Section VI). The phrase
fattening carbs was in
common usage. However, based upon the
research of John Yudkin, founding Professor of the first department of
Nutrition in the UK, Queen Elizabeth College, London, a strong base in science
blaming sugar was established. Yudkin
popularized the science in Pure,
White, and Deadly,1972, which is still in print. Science since has refined
the cause to that
of the fructose molecule, to which Prof.
Robert Lustig, science writer Gary Taubes, and nephrologist Jason Fung are
leading voices in the US and Canada. In
Europe, Australia, and Canada, their public broadcast networks have done
documentaries exposing the role of sugar—see my documentary page for links to YouTube. Taubes’
latest book 2016, The Case Against Sugar,
settles the issue, as does Lustig’s journal article which reviews the science behind his claim that
fructose is toxic to the liver in ways that parallel’s ethanol. A summary
of that evidence is in a 15 minute college-level documentary. It was Lustig’s lecture on UCTV on fructose, which I saw in 2012, that
started me researching full-time all aspects of the western diet and its role
in causing the diabetes and obesity pandemics.
Prior to that I assumed fructose was like glucose, just empty calories. I
pasted parts of the 2005 Wikipedia article
on fructose and sucrose on my website at link. In 2017 it
was because
of Taube, I began researching how fructose causes CAWD. This expansion now
includes an inventory of the ways in which fructose is a slow acting poison
very similar to ethanol—a point made by Prof Lustig repeatedly—his Buzz article.
The major theme in this paper is an expansion of his list with inclusion
of the biological processes that has pathogenic consequences. Thousands of journal
articles have been
published on the role of fructose in the development of insulin resistance (IR),
its progression to metabolic
syndrome (MeS), fatty liver disease
(NAFLD), obesity, and t2d.
I’ve added CAWD a consequence
of biological changes that fructose causes to the cellular repair systems functions.
The science is conclusive: fructose in excess is toxic in ways that
causes far more than other candidates the CAWD.
Of course the industries which profit are
trying to keep the pig in the bag.
e. Cognitive
dissonance and framing beliefs:
Without knowing what the main cause, minor causes are elevated to
fulfill that role. Thus there is a long
list of causes to which supposed major or refined carbohydrates, gluten,
saturated fats, meat, cholesterol, hypertension, stress, salt, GMOs, processed
foods, food additives, industrial chemicals, pesticides, and sedentary and
lifestyle. The looking of finding mice
while missing the elephant in the room has long history built upon industry’s
cash, scientists for hire and government and media support. Earlier notable
examples include cigarettes,
industrial pollution, cigarettes, exposure to chemicals at work, pharmaceutical
drugs, tetraethyl lead, GMOs, and sugar. Given the dispositive evidence against
fructose/sugar, it should be first before global warming. And it gets
worse in that the comparison of
causes for death among population life-long on a low sugar diet is verboten.
Instead the message is the healthy foods and drugs has extended our
lives decades. The 1871 UK population
study of men found that if taking only those age 21 and older (dropping out
childhood morality) that their life expectancy was just 3 years longer than for
men in men in the US (2010 census); their average age of death was 75-- see link. I
say this because understanding causes requires a realization that the media
implants pernicious memes. How can we
fail to realize that “the consumption of fructose and the fructose-containing
disaccharides sucrose for decease is at ~130 lb./year or 6.5 oz./day for the
average American”[5] is
causing our health disaster and that LSP
are free of those conditions? To quote Just
So Stories by Kipling: “Listen
and attend my beloved” and I will take you down the Fructose river to the
lassie fare port that permits food manufactures to cause CAWD , and you shall
know the place for the first time.[6] It is the story of tobacco retold. The scientific evidence was in by 1922 (see link), but it
took until 1964 for the Surgeon General to warn Americans about lung cancer;
but he skipped extra death from all cancers and from coronary artery disease,
which causes more extra deaths than cancer—see link. The message of tobacco was already out around
the world, and now Americans got the minimal federal government warning.
f.
Cognitive dysfunction: Industry’s
response and thus our corporate media is to have us looking under the wrong
trees, thus they don’t mention CAWD or fructose as toxic to the liver. Their tree’s main branches are
hypercholesterolemia, saturated fats, salt, hypertension, ratio of omega 3 to
omega 6 fatty acids, trans-fats, sedentary life-style, stress, gluten, sun
shine, low vitamin D and calcium, and a dozen more; and an even longer list of
miracle foods as fixes. Industry’s
favorite phrases: breakfast
is the most important meal, energy rich foods (avoid), artery clogging
cholesterol and saturated fats, a calories is a calorie, eat less and move more,
and ask your doctor; It’s
all bad advice, and if doctors knew
the answer then we wouldn’t have the diabesity and MeS pandemics. For over 40
years we have been following theirs and the NIH advice to eat low fat, and to
eating less and move more. The mountains
of tobacco science spouted by key opinion leaders (KOLs) and carried by corporate
media as to causes of chronic and
acute conditions and their fixes/prevention creates cognitive dissonance; it
smothers the evidence fingering fructose and sucrose in our western diet. For
example over and over again I read
journal articles where researchers investigating the health of LSP were
measuring cholesterol and triglycerides--only one measured serum insulin. What
follows is about fructose and how in
excess it mucks up our mammalian systems.
The last section is on how best to promote healing. The ability
to heal is in our DNA, and there
are ways to promote that process.
g.
Health
biomarkers of populations on a low sugar diet Lindeberg
found that comparing insulin levels of an aboriginal people--the Kitavan--to a
western society, only 5% of the Swedes had plasma insulin level below that of
the average Kitavan;[7]
and the Kitavans get 70% of their calories from carbs, most of which are easily
digested—see link. Based on Lindeberg’s[8] and Dr. Kraft’s.[9] work,
I estimate that over 80% of adults and over 90% of seniors have IR.[10] Dr. Joseph Kraft starting in the 1970s tested over 15,000 patients for IR[11]
by measuring for 5 hours insulin secretion in response to 75 grams of
glucose. He found that 80% of Americans
back then were IR, and that IR was
strongly associated with
atherosclerosis and ischemic events; the degree of risk depended on degree and
duration of IR. The work of Kraft
and Lindeberg confirm the
association of CAWD with IR.
Other key measures of issues are the reduced oxygen consumption of
American, the fasting leptin increase and blood pressure increase—see tables. The lower maximum oxygen consumption is an
indication of an issue with the mitochondria for those on the Western diet (see
Section IV k). Seminal works have
shown that IR is a marker for cancer and
another for CVD, and
numerous other works for t2d and
MeS, and
another for age related
conditions[12]. It is time to get off of the glucose &
lipid paradigms and focus on IR and
fructose. The elevated insulin
continuum from TOFI to diabetic
explains why both groups have the same set of CAWD—see section III. T2d
is the extreme form of IR, a form
which is caused by excessive fat accumulation in the pancreas (YouTube
and Newcastle
U
2015) resulting in pancreatic
inflammation and a pathological
drop in the production of insulin. Type
2 diabetics have the most severe form of IR
and thereby a greater risk for CAWD. The
case against fructose and IR as the
major cause for CAWD has the support
of an ever growing number of researchers and physician—see my video section
#3 Other than lipid measurements, comparisons
of biomarkers are few and limited.
h. IR
in the liver and
fructose: Is IR pathogenic? Or
is it just a marker for the damage caused
by fructose? I and others put the main
blame upon fructose, because fructose causes IR, see Section II. In various ways IR
is not only a sign of excessive long-term dietary fructose, but
also a contributor to CAWD. Insulin
is a major regulatory hormone,
thus elevated insulin affects several other hormones and its abnormal elevation
form IR has many pathogenic
consequences. IR is causal through
leptin resistance for weight gain: leptin lowers the rate of metabolism 25 to
40% when on a calorie restricted diet, and causes increased hunger by down
regulating the action of leptin in the hypothalamus. IR
increases insulin like growth factors (IGFs) of which IGF-1 is associated with
the growth of cancer. IR increases
fat storage, and thus is
causal for the accumulation of fat in the liver thus a casual factor for NFALD, and
there is a strong link
between IR and weight gain. Defects
in the
mitochondria result in underproduction of ATP, which has many effects of which
one is the underproduction of collagen (Section IV i).
Uric acid,
a byproduct of fructose metabolism, is responsible for
hyperuricemia uric acid which promotes nephropathy, endothelial
dysfunction, and other conditions (see Section
II f ). IR inhibits the express
of FoxO1, a key autophagy gene, 2009. This compromises the cellular repair system
in the liver and thus promotes damage to the liver by glycation and liver
inflammation, thus IR is causal for NAFLD
and other conditions associated
with the western diet. In these and
other ways, IR is pathogenic, and in
other ways not mentioned. These topics will be at length developed in
subsequent sections. Note A fasting serum insulin level greater than 25 mIU/L or 174
pmol/L is considered insulin resistance. The same levels apply three hours
after the last meal.
The path to CAWD starts with high sucrose diet, in
which fructose--one-half of the disaccharide sucrose--when consumed long-term
and in excess damages the liver by its conversion into fat and by glycation,[13] non-enzymatic bond. This combination leads to inflammation
in the
liver, fatty-liver, and liver insulin resistance. IR
will then develop in other tissues, mainly adipocytes and myocytes. This combination
of IR and liver inflammation mucks-up the various regulatory and
healing systems whose down-stream effects result in CAWD. Two major pathogenic
effects are an over production of uric acid and an underproduction of
collagen—see below. The evidence for the role of fructose as the first (starting) cause
is compelling; while the concern over glucose is the result of bad pharma
pushing their drugs—Section VI
II.
How
Fructose Causes Insulin Resistance
a. Introduction:
The
road to IR starts with fructose’s
whose effects in the liver in 5 ways differ from glucose, for which the end
result is IR in most tissues. The
main source of fructose is the
disaccharide sucrose; its other half is glucose. While it is net 20 more reactive
than
glucose: net in that is cleared from the
blood by the liver slower than glucose and is metabolized after glucose, thus
though 10 more reactive (see IV e) its presence as a liver toxin is twice as
long as glucose and longer depending on amount of glucose in the meal.[14] This is further compounded by the fact that
the clearance of fructose is reduced in those who are diabetic compared to the
non-diabetic and presumable to a lesser extent by those who are IR, though not
address in research that
I know of.[15] “These results
suggest that fructose is closely involved not
only in glycation but also in the polyol
pathway [making cellular fructose] and peroxidation reactions through free
radical formation. Thus, fructose is
considered to be a more critical reducing sugar associated with the
progression of diabetic complications than it has been thought until now” Kobe 2002. Because of the CAWD,
it is reasonable to assume that the pathological findings for t2d extend to those
who are merely
insulin resistant or had been because of the western high fructose diet.
b. Metabolized
by the liver: One
of the livers functions
is to dispose of toxic chemical, thus fructose is transported to the liver for
disposal. A high sugar diet overwhelms
first the first protective system the small intestines (Science 2018) that metabolizes small
amounts of fructose. Overloaded the
excess is sent via the portal vein to the liver where it is stored until
glucose in the liver is sufficiently low.
On the Western diet ninety-five percent of
serum fructose is handled by the liver.
Unlike glucose there is no storage (glycogen) form for fructose. Fructose being a net 20 times more reactive than glucose can
overwhelm the cellular repair systems in the liver (and in other tissues). While only about 20% of glucose goes to the
liver for metabolism an estimated 95% is metabolized in the liver.[16] Glucose is metabolized first in the
mitochondria, thereby delaying the metabolism of fructose. This delays fructose’s
metabolism when part
of a high-carb meal; thereby, increasing fructose’s toxic effects.
c.
Fructosylation of proteins: in a non-enzymatic reaction of the reducing sugar fructose (often
called glycation).[17] Fructose attaches to certain amino acids
mainly on proteins. Fructose and galactose are the most reactive of the common
monosaccharaides. “Reducing sugars have an affinity for the amino acids lysine,
methionine, and cysteine, of which the latter two [can] undergo a reversible
oxidation, and thus act as an antioxidant—at 2013.[18] Fructose because if forms a 5-unit ring (4
carbons and an oxygen) while glucose forms a 6-unit ring (5 carbons & an
oxygen); thus there is greater strain upon the carbon to carbon bonds in the
smaller ring; and as a consequence, fructose goes into an open straight chain
form significantly longer and more often than glucose. In this open form, fructose
is capable of
latching on to certain amino acids in a process known as glycation to form a
fructosamine, which are further modified by
reactive oxygen species—see 1989. Non-enzymatic
attaching to proteins alters their functions—a bad thing. Since fructose is
more reactive and its clearance is delayed by glucose by metabolism, a
reasonable estimate of the amount of glycation in the liver by fructose
compared to glucose is a net 20 fold greater (10 x 2 because of delayed
clearance from liver—(depending on method of measurement). “Fructose undergoes the Maillard reaction, non-enzymatic browning, with amino acids. Because fructose exists to a
greater extent in the open-chain form than does glucose, the initial stages of
the Maillard reaction occur more rapidly than with glucose” Wiki, 2017. “Some of the
products of this reaction (acrylamides) are known carcinogens” Wiki. “The
Maillard is a step in the formation of advanced glycation
end products (AGEs). It has also shown a correlation in numerous s
different diseases in the human body….
In general, these diseases are due to the accumulation of AGEs on nucleic acids, proteins, and lipids” Wiki 2017. The mechanisms which have evolved to protect
mammals from the damage by glycation from glucose on a high carbohydrate diet,
such as superoxide dismutase and autophagy, are overwhelm by our western diet
high in fructose—not glucose see II j below. This excessive
formation of these end-products in the liver to
adversely effects liver function and causes a higher rate of complication associated with
t2d, and those with
insulin resistance.
d.
Fatty liver: In
the liver fructose is converted to fat at a much higher rate than glucose. “By
liver metabolizing glucose first, this will when there is sufficient ATP, cause
the conversion of fructose to fat by de novo lipogenesis. Thus, fructose-generated ROS species
are abundant (66, 67) and require quenching by a hepatic
antioxidant (e.g., glutathione,
ascorbate, superoxide dismutase, et al) or hepatocellular damage will
result (Fig. 4). The hepatotoxic effects of fructose via ROS formation have been demonstrated in
both cultured hepatocytes (68) and animal models (69). Although mechanistic data in humans are
difficult to obtain, case-control studies demonstrate that fructose consumption
correlates with the development of hepatic steatosis and nonalcoholic
steatohepatitis (70–72)” Lustig
2013. Uric acid a product of fructose
metabolism generates ROS which
stress the mitochondria and thereby has a role independent of fructose in the
development of fatty liver—a seminal article at 2012, “[U]ric
acid upregulates
frictokinase expression thus leading to the amplification of the lipogenic
effect of fructose”, 2012. Gradually with
long-term high sugar diet this will lead to excessive storage of fat in the
liver. The rate of fat storage in the
liver is controlled by the level of insulin, level of glucose, and the level of
fatty acids in the liver. Excess free
fatty acids are converted to triglycerides, the water insoluble storage form,
made up of 3 molecules of fat bonded to glycerol. With sufficient accumulation
the condition is
known NAFLD –certain drugs including ethanol can also cause a fatty
liver. NAFLD can progress to NASH
(Non-alcoholic steatohepatitis) in which
there is the combination of inflammation and fibrosis—estimates run between
2-5% in the US. Over a 10
year period about 20% of those with
NASH will progress to cirrhosis of the liver. But much more is at stake with
development of
fatty liver, for example liver fat and hyperinsulinemia are the two best
markers along with C-reactive protein for MeS
at Sept
2007 abstract. In
summary
2007: “We conclude that increased liver fat is associated with both
impaired insulin clearance and hepatic insulin resistance. Hepatic insulin
sensitivity associates with liver fat content, independent of insulin
clearance.”
e. The two
hit hypothesis for NAFLD and hepatic inflammation: The two
processes above, conversion to fat and the production of reactive oxygen
species as a result of glycation by fructose are the main causes for the
inflammation of the liver leading to NAFLD—see
2009[19] If
fructose was comparable to glucose in the rate of glycation, then the 15% of
calories from fructose that a fair number of sugar addicts consume would be
comparable to 70% of calories that the Kitavans consume as carbs, yet the
Kitavans have very low insulin and fasting glucose (see section I). But these
sugar addicts test much worse than
the Kitavans, the difference stems from the glycation by fructose. The same
argument can be made for the
traditional Japanese and other high starch diet peoples. It isn’t just
de novo lipogenesis in the
liver. Fructose is 10 times more
reactive than glucose. The major
difference is glycation (fructosylation), the 2nd essential punch. Among the signs of damage to hepatocytes
includes reduction in size of mitochondria and thus reduced production therein
of ATP, which is observed with t2d. Others
include reduced
production of collagen
in the polyol pathway. Even though fructose is transported to the
liver and is more reactive than glucose, many authorities assume only one hit,
fatty liver (Fung, Lustig,
and Taubes et al.),
and a few add a third uric acid (urate), which is a product of fructose
metabolism.
f. Uric acid from fructose metabolism promotes
IR “ Fructose is
a major component of added sugars and is distinct from other sugars in its
ability to cause intracellular ATP depletion, nucleotide turnover, and the
generation of uric acid”, at 2013 “Here,
we show that fructose also
stimulates triglyceride synthesis via a purine-degrading pathway that is
triggered from the rapid phosphorylation of fructose by fructokinase. Generated
AMP enters into the purine degradation pathway through the activation of AMP
deaminase resulting in uric acid production and the generation of mitochondrial
oxidants. Mitochondrial oxidative stress results in the inhibition of aconitase
in the Krebs cycle, resulting in the accumulation of citrate and the
stimulation of ATP citrate lyase and fatty-acid synthase leading to de
novo lipogeneis. These studies provide new insights into the
pathogenesis of hepatic fat accumulation under normal and diseased states” at 2012. The
study shows how de novo lipogenesis is
promoted by a product of fructose metabolism, uric acid. Another study shows
that uric acid also
stimulate fat accumulation via generation of endoplasmic reticulum stress and
SREBP-1c activation in hepatocytes. The
study (supra) takes us from association to causality—2014, again with Richard J. Johnson et al—he was on
the team that produced the other 2 sites supra.
Since fatty liver is causal for insulin resistance and insulin
resistance for obesity and diabetes, this work adds a major pathway for major
conditions associated with the Western diet through the action of uric acid
upon the mitochondria, and upon stimulating de novo lipogenesis.
g. Defective mitochondria:
Type 2 diabetics have defective mitochondria, at 2005, 2006. “A reduced
basal ADP-stimulated and maximal mitochondrial respiratory capacity underlies
the reduction in in vivo mitochondrial function, independent of mitochondrial
content. A reduced capacity at both the level of the electron transport chain
and phosphorylation system underlies this impaired mitochondrial capacity”, at 2008. As maintained
those with IR in the liver which is caused by the
high fructose diet will develop in other tissues defective mitochondria similar
the diabetic but to a lesser degree. This
will causes a
decrease in the production of ATP through the Krebs cycle, and as a consequence
an increase in cellular and serum glucose. In the liver and conversion rate of glucose to glycogen and the
production of ATP has decrease due to defective mitochondria and the effects of
inflammation caused by a fatty liver, thus slowing the utilization of glucose
and raising serum glucose, the hallmark of IR—see 2008 and 2011. Cells throughout
the body already load with glucose become resistant to the uptake of more
glucose as the liver’s functions decline. Through a feedback mechanism these body
cells become resistant to the uptake of more glucose. Added to this is the
Crabtree effect: a high level of glucose
down regulates glucose metabolism (inhibition of respiration), “that effect was
strongly antagonized by fructose 1,6-bisphosphate (F16bp). . . . as able to
inhibit mitochondrial respiration.
. .” at 2008. This combination of factors explains
the development of insulin resistance in tissues besides the liver.
In
the liver some of the fructose enters
the Krebs cycle to produce ATP. Though
fructose is invisible to insulin by entering the Krebs cycle and thus slows the
cellular and serum uptake of glucose. This
explains why fructose though invisible to insulin, has a glycemic index (which
measures glucose uptake from foods) of fructose is between 19 to 23, while
glucose is rated at 100, and sucrose at 60 (thus not 50). The rise in insulin
is because of the slower
metabolism of glucose and slower uptake through the GLUT-5 transport
system. Unfortunately I could not find
any articles on the mechanism by which mitochondria become defective. The most
likely cause is excessive production
of ROS and glycation by fructose
(fructosylation) within the mitochondria. Whatever the process, the lowered
rate of
production of ATP causes a slowed clearance of glucose and thus reduced rate of
uptake of blood glucose. Thus the beta
cells release more insulin; viz., excessive insulin is by definition insulin
resistance.
h. Inflammation
of the liver: This damage to the liver is by glycation and
compound by the excessive storage of 2-3 pound of fat; this causes an inflamed
liver and thus elevated C-reactive protein 2007. This condition is known as non-alcoholic
fatty liver disease (NAFLD). This
combination of two process has been established
in animal and human experiments; however, most authorities stress the 3rd
factor fat storage (it is easy to measure with a sonogram of the liver), while
missing the additive role of fructosylation—see protein
oxidation, 2013, and
2008.
j. Insulin resistance
in the liver: This
is a response by
hepatocytes to the excess storage of fat in the liver and the damage caused by
glycation mainly by fructose, and compounded by the hepatocytes having
sufficient glucose and fructose, and thus resisting the uptake of more plasma glucose
(a point made by Dr. Jason Fung in his 2016 books, see supra). The damaged hepatocytes
are not clearing the
cellular sugar at the rate prior to damage.
As liver functions decline
the liver cells become resistant to insulin signal for the uptake more glucose
than fructose; they both use the GLUT 5, GLUT 2 and possible SLC2A9 transport
system and with insulin resistance these
transport system don’t work as well.
Moreover the level of fructose, in a vicious cycle, increases with
increasing insulin resistance, the highest
level being among type-2 diabetics.
j. Insulin
resistant in other tissues: Eventually IR in
the liver, depending on lifestyle, genes, hormones, and age, can develop into IR
in other cells especially the
myocytes and adipocytes—along with the brain & liver, these cells consume
most of the glucose. Insulin resistance
is the result of a feed-back system protecting the cell from having glucose in
excess of what it needs. Also causal is
“elevated lipolysis and the release of free fatty acids into the blood stream
which contributes to further insulin resistance via increasing hepatic
gluconeogenesis and preventing insulin dependent uptake in tissues” Wiki.
k. Fatty
pancreas causes t2d:
the work of Joseph Kraft and 3 decades later Roy
Taylor and team at Newcastle University have shown that as insulin resistance
progress, it drives fat storage into tissues throughout the body, and
eventually excess fat will be stored in the pancreas and result when sufficient
in excessive stores like the liver the pancreas becomes inflamed and the
production of insulin dramatically declines to become symptomatic hyperglycemia
which is treated with drugs or through a low carb diet.[20] Healthfully articles on t2d and Roy Taylor’s work. {need
to
paste his journal article.
I.
Metabolic syndrome (MeS): MeS its cause is the western diet. Not surprisingly the list of signs
associated
with increased risk of CVD events
should be spun to promote the sales of drug.
Nevertheless, It merits discussion because the conditions have become
accepted by physicians and public though the consequences for most of the
markers don’t put the person in the high risk group for CVD. It is defined
by the American
Heart Association as 3 of the 5: 1) unmedicated fasting plasma glucose greater
than 100 mg/dL, 2) HDL cholesterol under 40 mg/dL, 3)Triglycerides greater than
150 mg/dL, 4)waist circumference greater than 40 inches men, and 35 for women,
and 5) unmedicated systolic blood pressure of 130 mm Hg. Of the five associated
with CVD, all of these are grossly flawed,
for example #3; includes a significant percentage of people at lower risk for CVD
such as those who as part of
physical because they eat lots of high carbohydrate foods in their diet while
in physical training. And number #4 is
flawed because many obese short people would be missed. missing short people who would be considered
at low risk but aren’t. The cholesterol
myth has been amply debunked in the literature and summarized at link. Systolic blood
pressure of 130 to 140 would include athletes and other fit people. Having
said this, the markers associated with ischemic events are the western high
fructose diet, insulin resistance, elevated plasma glucose without medications,
systolic blood pressure above 150 mg/dL, associated with atherosclerosis,
angina pain, sedentary lifestyle because of being incapable of run and swim
laps, polypharmacy, overweight, abdominal fat, and all the conditions
associated with western diet when past the age of 50.
M. Not
refined grains (glucose) alone: Given
those populations that eat or once ate a high-carb easily digestible, low-sugar
diet don’t experience CAWD (Kitavans,
Japanese, Okinawans), this is strong evidence glucose isn’t by itself causing CAWD,
but rather that at some point
there must be a protracted period of intake of fructose averaging over 50 grams
a day (less for the elderly and inactive).
Many authors are not aware that fructose is a reactive sugar, and that it
damages the liver to cause IR. A
second error is the claim that real foods
are much more healthful, and foods high in refined carbs aren’t because of
their low fiber content. However, the
populations named above consume foods low in fiber, but this doesn’t mean that
fiber is not of value when on a Western diet; but its value is small when on a
low sugar diet. This is like the error
concerning antioxidants supplements, they are helpful for those on a western
diet. On a life-long low sugar diet, the over 50 cellular repairs system, a
number of which utilize cellular manufactured antioxidant such as glutathionene
and CoQ10.
About 3 hours later, on
a meal with half carbs, the mitochondria begin taking up the fructose and metabolize
it into the trioses dihydroxyacetone and glyceraldehyde which can enter the glycogenic
“pathway leading to glycogen synthesis
as well as fatty acids and triglyceride synthesis” wiki
2018 and fatty acids from the production of pyruvate which is
converted to acetyl-CoA and then fatty acids or through glycerol-3 phosphate to
fatty acids. Unlike glucose, fructose’s end product can also be uric acid: “The
fructose component of sugars increases
serum levels of uric acid. “The striking
increase” in those levels with an infusion of fructose was first reported in
the late 1960s by Finnish researchers. . . .”
Taubes The Case Against Sugar
p 241-2.
He goes on to describe how through its effect on ATP breakdown through
“adenosine a form of adenine, a purine” and “the effect of fructose on works to
stimulate the synthesis of purines, and the metabolism of fructose leads to the
production of lactic acid, which reduces the excretion of uric acid by the
kidney and thereby raises uric acid levels indirectly.” Supra 241.[21]
The amount of fatty acids and triglycerides is controlled by the cellular need
for glucose. Fructose is far more pathogenic than glucose, and too many
authorities fail to mention the differences.
As Prof. Ben Goldacre repeatedly writes in Bad Pharma “The devil is
in the details.”
n. Summation:
While the journal evidence is weak other processes
that are
causal for CADW, in particular uric
acid, lowered rate of replacement of collagen, and glycation by fructose, they
are likely also contributing causes for the issues leading to beta cell
dysfunction resulting in t2d and IR.
On point is the over expression of fructose-1-6-bisphosphatease in
pancreatic beta cells causing reduced secretion of insulin and increased
pancreatic fat are causal for t2d--2008. Moreover through
glycation and thus oxidative stress fructose promotes apoptosis (but not
glucose)[22]
in beta cells, the more so with fructose being the most reactive 96, and in a higher level in the pancreas.
The progression to t2d
is associated with a list of comorbidities, and as insulin levels go up through
medications to lower glucose, these comorbidities increase, especially weight
gain, due to insulin’s function of promoting fat storage. The elevated
glucose both stimulates the
polyol pathway which produces sorbitol and fructose and slows by selective
metabolism of glucose first, an increase in the level of fructose. This focus
on managing glucose while good for
pharma, this is another misdirection of treatment and research which should
focus on lowering fructose. That the ADA
has among others recommended
replacing sucrose with fructose, while lowering the need postprandial
medication in the long-run is pathogenic.
Management should be on lowering fructose. And this can best be achieved
both for t1d and t2d by lowering
carbs, which among other things doesn’t turn on the
polyol pathway that produces fructose.
In section VI, this topic of dietary control and cure will be briefly
developed.
III.
Consequences of Insulin Resistance (IR)
a.
A review of the role of excess fructose: Insulin resistance starts with the Western high fructose diet. Although sugar cane was grown
since the 7th century,
the mass important into Europe occurred in the 18th century. France
is the early 19th century, under the direction of Napoleon
selectively bred beets for higher sugar content. Today sugar beets
account for about 20% of sugar. In the 19th century,
the consumption of high sugar products became affordable to
all. “In the US in 1830 went from less than 15 pounds [18.7
gram/day] a person yearly to 100 pounds in the 1920s and 150 pounds . . .by the
end of the century.”[22] About 20% of
glucose and all of fructose is transported into the
liver. Fructose is a net 20 times more reactive than glucose,[23] and it nearly
exclusive metabolized in the liver. Our high fructose diet overloads the
systems that repair glycated proteins and their oxidized end products.[24] Glucose
alone being less reactive can’t cause insulin resistance. With a
high carb meal, the excess glucose causes a delay in fructose metabolism, and
also increases its conversion to fat in the liver by de
novo lipogenesis—also 2010. The
production of ATP is controlled by
need, and with a high carb diet, when sufficient ATP is produced, the excess
is converted to fatty acids which are
converted to triglycerides. To promote
glucose metabolism, insulin also signals fat storage; this gradually leads to a
fatty liver (similar to that caused by ethanol). There is very
strong evidence supporting the role of fructose; for example, in a trial in which young-healthy volunteers were
fed 40% of calories
from fructose; within 2 weeks they developed insulin resistance and fatty
liver. This is consistent with animal studies using a lower
dose. Prof. Robert Lustig has done a sophisticated population study
of over 100 populations; they controlled for confounding variables. His team found that only for the
disaccharide sucrose is there a strong association with metabolic syndrome—the
same type of population study done to prove that cigarettes cause lung cancer.
This one two punches of fructosylation damaging hepatocytes and fatty cells
drives insulin resistance in the damaged liver as it lowers the import of
glucose into the hepatocytes. The liver plays a major role in
controlling plasma glucose which is down regulated, thus increasing serum
glucose, and thus more insulin. This eventually this will lead
to IR in the myocytes and adipocytes as they resist excess
glucose uptake and thus become IR. Insulin promotes fat
conversion to the storage form of triglycerides and also regulates other
hormones that are part of the weight-regulatory system, of which insulin is an
antagonist of leptin at the hypothalamus (see leptin resistance Section III d),
thus insulin resistance is the major cause for weight gain.[25] See rmb/5Figure 1 for insulin
levels of LPS and healthy Swedes whose level is 90% above the LSP, and Swedes
have a much lower rate of obesity. Even moderate
weight gain (TOFI) is strongly associated with IR, high
sugar diet, and CAWD.
b.
storage: IR not
only promotes the uptake of glucose, but also shuts down
the metabolism fat to promote cellular glucose metabolism. The fat is then converted
to the storage form
of triglycerides, and IR potentiates
that effect of insulin thus the fundamental cause for excessive (not natural)
weight, typically averaging about 1% of caloric intake, about 25 grams a
day. “Just a 1 percent excess of e nergy
consumption (over expenditure), for instance, could cause an average size man
to gain 60 pounds over 30 years” (What
Fuels Fat, JS Flier Dean of
Medicine Harvard University, and EM Flier MD, Scientific American, 2007, p
73). With long-term weight gain, the
adipose tissue functions to maintain its adiposity when weight is being loss by
lowering metabolisms and increasing appetite—click on link for journal articles on point.
b. Weight
regulatory system: Humans, like
all mammals, have a complex system of regulatory
hormones that controls appetite, metabolic rate, fat storage, glucose storage,
nutrient absorption, and like, therefor there are over 80 hormones involved in
these systems regulation. That system is
set promote the ideal weight for seize, circumstances, and age. In the wild,
an overweight animal among their
species is exceedingly rare, even during food surpluses. It is exquisitely controlled:
animals only in
preparation for hibernate or migration is weight put on. For humans, like other
processes such as
wound healing and growth, weight too is tightly controlled for those lifelong
on a low-sugar diet (with the rarer exceptions driven by societal norms). Even
the elderly aboriginals retain their
natural weight, for example, a man weighs an average of 7 lbs. less as they
lose muscle mass and women over twice loss through muscles and the loss of
fat-stores from their fertile years.
The two most important of the regulatory hormones are insulin
and leptin, and insulin regulates in part leptin.
IR not only directly
promotes excess fat storage but also through other hormones including leptin
causes the regulatory system rest as “normal” the gained weight. Without
insulin resistance this wouldn’t happen. (As stated prior over 90% of
those on a
western diet are IR using the
measurements of those on a traditional diet as a standard.) There are at least
4 other hormones besides
leptin secreted by adipose tissue.
Though regulation is complex, the initiating cause is our high fructose
diet—all else is downstream.
d. Leptin
and leptin resistance: insulin up
regulates leptin thus insulin resistance eventually in response to the excess
of leptin the receptors
for leptin in
the hippocampus become resistant to leptin.
Leptin is also responding to hormone from the adipose tissue, and
functions to keep a biologically determined amount of fat. With insulin resistance,
a signal is sent to
increase the amount of fat. Excess
leptin increases hunger to cause weight
gain, and that fails, typically at 2 months it will reduce the rate of
metabolism. When weight is being lost, leptin resistance through its action in
the brain causes increase in appetite as first response then a couple months
reduction in metabolism. This reduction
in metabolism, adversely affect how that person feels both physically and
mentally, and through these negative effects creates the urge to eat more so as
to feel better. This leptin driven
effects is why nearly all dieters with significant long-term weight will
gradually gain back most of the weight they had lost over
several years, and some even more than when they began their diet.[23] This confirms what Prof. Lustig says,
“biology rules.” He uses the example of
obese babies. Insulin resistance through
leptin and other regulatory hormones is driving the obesity epidemic, thus weight
gain is a sign for the high fructose diet, or past fructose amounts that caused
the fatty inflamed liver that plays a key role in developing insulin
resistance.
Leptin is a
hormone secreted by adipose tissue
which regulates appetite, metabolism, & functions to restore fat storage to
its set level through reducing the rate of metabolism from 25% to 40% and
increasing appetite. With long-term
excess weight, the normal weight (level of fat) is reset; thus making eating
less and exercise more is futile—the yo-yo diet. Leptin, typically during
the second month of
a diet will lower metabolism and increase appetite for to maintain “normal
weight”. If leptin-insulin system is
working right, that person without efforts stays at normal weight—like the
aborigines. Weight gain is strongly
associated with IR[24]. Pharma
profits from
having doctors focusing on lowering plasma glucose and treating CAWD; thus their
ignorance about the
weight regulatory system and how to fix it.[25] And pharma through their KOLs recommend “eating
less and moving more” advice that doesn’t work in 95% of the cases;
thus doctors are taught that diabetes is a progressive condition.[26]
e. Cellular
hyperglycemia: By using the measure of
the lsp, the level of glucose is
well above that of those people and is a sign, like hypertension, one in the
main a sign of insulin resistance, the other in the main of atherosclerosis. I
thus hold both abnormalities in themselves as only moderately pathological,
though pharm treats these sign, and consistent with its business model, the
benefits aren’t there.[27] Dr.
Jason Fung and others have developed this topic. In chapter 11 of his Diabetes Code, pages 138
to 150 uses clinical trial shows that
tight management of glucose confers no important benefits such as lower death
and prevent heart attacks, and given that these are pharma funded studies,
adjusting for scientific fraud, the results in the real-world population is
negative. He found 2 possible exceptions
(assuming fraud isn’t extreme) in the dipeptidyl peptidase-4 inhibitors (DPP-4)
and the sodium glucose cotransporters inhibitor (SGLT 2)). Note
after 3 hours of searching I was not
able to find serum glucose levels for those populations on a low sugar
diet. Lindeberg in is studies of the
Kitavans used insulin and leptin levels, which is superior to fasting glucose
and HbAIc because excess insulin (IR) keeps these markers in the normal range. Only
with an insulin assay reveals the
underlying IR consistent.[28] Using
insulin levels, the Kitavans on a traditional diet have levels 45 to 50 % below
those of healthy Swedes.
f. Type-2 Diabetes: Insulin
resistance causes t2d through the
accumulation of fat in
the
pancreas, which when it reaches
a critical point cause a significant
decline in the product of insulin, an effect similar to that of excess fat in
the liver causing NAFLD and its subsequent
reduction in liver functions. This
process parallels that in the liver of glycation by fructose which causes oxidative—1996. The IR
which causes weight gain, fatty liver, also causes accumulation of fat in
the
pancreas—watch Prof. Roy
Taylor’s lecture and, Dr. Jason
Fung, and in Taylor
2015, Science
News. Thus the combination
of oxidative stress and fat accumulation causes t2d. The other pathological
process such as
underproduction of collagen, stress by uric acid, etc. are all likely
contributory.
Pharma
teaches that the problem lies in insulin receptors on cells which have become resistant
to insulin signaling for uptake of
glucose, thereby causing the pancreas to release more insulin, and that over
time the beta cells in the pancreas become (permanently) exhausted from their increasing
production of insulin and production declines sufficiently to cause t2d.
Pharma hold that t2d is
progressive requiring ever increasing medications to stabilize serum
glucose. Pharma and the ADA[29]
teach that their
isn’t a cure, thereby they ignore the
counter examples or “explain” them
away. One is that with significant
weight loss there is a reduction of medications. Pharma also teaches that the
consumption of
carbs is not pathogenic, and that the patient should eat frequent snacks with
carbs to stabilize their insulin level and avoid hypoglycemia caused by their
medications. They also hold that the
morbidly obese type-2 diabetics who undergo bariatric surgery, that their
reduction in medications is because of weight loss. And pharma holds that tight
management of glucose based on DCCT Trial and the EDIC Trial prove that
tight control of glucose avoids major adverse events; however, the trial was
done with type 1 diabetes, and type 1 is the near zero production of insulin,
while type two there is significant production of insulin but not enough to
keep glucose in the desired range.[30] As Prof. Ben Goldacre says in Bad
Pharma, “The devil is in the
details.”
To arrive at these conclusions resulted from “cherry picking” the
evidence, used 2 inappropriate trails and others of very low quality, ignored
counter examples and scientific fraud which is buried by the fact that pharma
won’t share the raw data when submitting a trial for journal publication. The
article was published
in the NEJM and is
based upon raw data. Four professors
found the average bias was 32% in journal articles—that amounts to scientific
fraud.
Contrary to
pharma and the ADA, as for no cure there are many examples to the contrary
including that 80% of diabetics are cured of t2d or have a major reduction in
medication, and the improvement
occurs before major weight loss. The
Bata cells are not burnt out but rather producing less insulin because of fat
and inflammation--Fung 2017. Unfortunately, most of the patients aren’t
warned about sugar, and thus that they would revert to weight gain and t2d through
consumption of sugar. Critics[31]
of pharma hold that the issue isn’t the receptors’ resistance to insulin, but
rather the cells that have become resistant to taking on more glucose than
needed. They hold that it is much
better to go on a
very low carb diet and lower their need for medication—the opposite of
guidelines, ADA, and pharma’s recommends.
That 80% of
diabetics who subsequent to bariatric
surgery are cured is
attributed by pharma KOLs to their weight loss; however, the reversal of the
condition occurs before substantial weight loss, most within the two month.[32] The IV feeding subsequent to the operation is
essential a fast, one in which calories average under 600 per day. The
dietary fix for t2d, though successful for over a century, is the knife in the
back
of pharma’s spin. Fredrick
Allen reported cures of some of his
patients on a ketogenic diet in 1913.[33]
This treating of symptoms instead of the conditions is a common
business practice of pharma, like treating fever instead of infection. The consequence
is that pharma frames the
understanding of the diabetes and the search for treatments to lower the sign,
high glucose, rather than search for what has gone wrong with the weight regulatory
system, how best to cleanse the liver and pancreas of excess fat, and thereby cure type-2
diabetes with diet, and. And they blame the comorbidities of t2d on
glucose toxicity, thus requiring tighter control of glucose. However, by razing
insulin level these
conditions become more common, which leads some to refer to insulin toxicity, though I
hold that it is mainly the downstream effects of fructose that is the main
causal factor, and insulin resistance is a consequence of fructose toxicity—a
position held by Prof. Robert Lustig and others.
f.
Elevated Insulin like growth factors (IGF): When insulin goes up
so does IG-1. The significant of this
and the other IGFs are not clear. IGF-1
(the best studied of them) promotes of the utilization of amino acids, at
2014. It is on this
basis
that thought to accelerate the growth
of cancers. Given that
there are
six binding ligands, at least two IGF, and that they function mainly “part of
a complex system that cells use to communicate with their physiologic environment” (Wiki) even though they promote the growth of cancer, their net
overall effect as to health and their being over produced by those insulin resistant,
the overall net effects has
not been worked out—as far as I know.
Moreover, the connection to the growth of cancer might be just a marker
for plasma level of amino acids, and the putative growth of cancer might not be
promoted by the IGFs, but rather by the availability of amino acids used in
cell growth. For the sake of completeness,
I have included a reference to the possible role of IGFs.
h. Downstream
changes caused by IR:
Insulin functions in a number of regulatory systems affecting metabolism
of carbohydrates, fats, and amino acid, and thus affects their serum levels,
glycogenesis, lipogenesis, conversion of glycogen to glucose in the liver, and
the converse glucose to glycogen, synthesis of proteins, decreases proteolysis,
decreases autophagy, increases secretion of hydrochloric cells by parietal
cells, increases potassium uptake, and decreases sodium excretion. Insulin affects
the level of other hormones,
among them leptin, adiponectin and ghrelin—and this is not a complete list, see appendix 4?.
These hormones then have an effect upon the formation of
advanced glycation end produces (RAGE), the functions of endothelia nitric
oxide synthase (eNOS), glyceraldehnyde-3phosphage dehydrgenase, increased
production of fructose and sorbitol in the polyol pathway and regulation of
intracellular osmotic pressure, manganese superoxide dismutase (MnSOD), nuclear
factor kB (NFkB), poly(ADP-ribose) polymerase, protein kinase C, I GF-1
(Insulin like growth factors), uric acid, delaying replacement of collagen and
endothelial cells, rate of metabolism in the tricarboxylic1 acid (TCA) cycle,
uncoupling proteins, and others. The complexity of compromised functions
caused by excessive dietary fructose causes a long list of CADW. This contrasts with
the simple clinical consequence of a deficiency of thiamine (vitamin B1),
beriberi. There is need for major
research efforts to sort out the role of insulin resistance in CAWD.
A similar effort is need for the effects of glycation of proteins and
the oxidation of unsaturated fatty acids.
And we need to keep businesses out of funding scientists for hire to
sullying the evidence base on which medicine is practiced. You’d be surprised
at how many drugs are not
worth their side effects—far more than Evans and Debree claimed, link.
The third
points turns upon what is being measured and that the
reactive sugars is not being measured. Fraud http://healthfully.org/index/id9.html
i.
Fetal environment promotes IR: a mother with IR--elevated
postprandial glucose- significantly increases the risk
in her offspring of being born with or developing IR and thus obesity and other
CAWD.[34] The elevated glucose and insulin cross the
placenta and affect the fetus production of GLUT receptors for insulin an
glucose and fructose transport. This
increase in receptors increases the response to sugars thereby increasing the
risk for IR. Each generation, as
we have observed, has a
higher rate of obesity and IR than
the previous.
[1]
Testing is done to find what combination consumers prefer, and this is called
by industry “the bliss point”.
[2]
Fructosylation is the latching on to amino acids in proteins by fructose. Since
fructose is a net 20 times more
reactive than glucose (net because its clearance from the liver occurs after
glucose). For simplicity I will skip the
minor process of glycation. Note, pharma
through their KOLs teach glycation by glucose, while ignoring the role of
fructose, which is why most researchers focus on fatty liver. Some focus on
inflammation and reactive
oxygen species, but it isn’t oxygen or glucose, but fructose that buggers up
the systems.
[3]
The two are not independent, the supply in most cases is dependent on the need
of the mitochondria, to which there are hundreds to 2 thousand in a cell. The
oxygen is for metabolism and for reasons
develop later the mitochondria become damaged (visibility evident) and consume
less oxygen, thus hypoxia.
[4] Staffan Lindeberg’s study on line is in PDF,
which is difficult to convert to MS Word and doesn’t have a HTML address for
link.
[6] A
quote by T.S. Eliot: Science so not
cease from exploring, and
arrive at where it started and know the place for the first time.
[7]
Results dependent on definition. A very
telling figure is on the Kitavans, Pacific Islanders who eat a traditional diet
with 70% of calories from carbohydrates.
In the study
of Dr. Lindeberg, he measured 196 Kitavans blood insulin
levels: “The average Kitavans had
insulin levels lower than 95% of Swedes.”
Dr. Jason Fung, The Obesity Code 2016,
p. 105.
“Three of four Kitavan males and females were daily smokers…. Whereas
atherothrombotic disorders were absent or rare” Linbeberg,
p. 1217.
[8] “For example, the mean insulin
concentration in 50 to 74-year-old Kitavans was 50% lower than healthy Swedes, see Figure 1.
[9]
The blood work that measures fasting glucose and HBA1c can be in the normal
rage because elevated insulin has brought glucose within the normal range, thus
Kraft and other a generation ago measured along with the serum glucose in the
test the level of insulin. Today,
instead of performing a glucose tolerance test and measuring insulin instead,
pharma has true to form, has complicated
the insulin test in a way that makes it costly and time consuming, and it
dangerous (can induce a diabetic coma); thus
its use is in research. Insulin
is injected to induce extreme hypoglycemia (below 40 mg/dL)
[10]
Reliance upon Fating glucose and HA1C as measurement for IR is misplaced, because
excessive insulin produces a normal
reading.
[11]
He called it “diabetes” though by today’s usage it is called “insulin
resistance”.
[12]
“The
fact that an age-related clinical event
developed in approximately 1 out of 3 healthy individuals in the upper tertile
of insulin resistance at baseline, followed for an average of 6 yr, whereas no
clinical events were observed in the most insulin-sensitive tertile, should
serve as a strong stimulus to further efforts to define the role of insulin
resistance in the genesis of age-related diseases.”
[14]
In measuring glycated hemoglobin (HB1ac) I do not know if the assay most
commonly used measures glycation by fructose and to what accuracy. If it doesn’t
than the difference between
those on a low sugar diet and those on the western diet, those figures need to
be adjusted. If one has that answer,
please contact me at jerome69@sbcglobal.net
[15]
In a study of non-diabetics to those with t2d,
the serum level of fructose was 50% and the daily urinary fructose excretion
was 300% higher—Feb 2002.
[16]
See Taubes, p. 200, Bad Calories, and
Lustig p. 123 Fat Chance. Some older sources give a lower
percentage of uptake by the liver.
[17]
Quite annoying, many terms are used in ways that favor pharma. To this list
I would include glycation when it involves a sugar other than
glucose, such as fructose. Another is oxidation
and reactive
oxygen species (ROS), when
it is a sugar that bonds to a protein in a non-enzymatic Milliard
reaction. Another is to call cholesterol
a lipid, because most people think it to be a
fat looking like in an atheroma—see
photo at link. However, cholesterol is a
white crystalline substance like sugar, with a melting point of 300⁰F. An autopsy
study found that plaque contains 7 to
22% cholesterol—see MI.
[18] “Furthermore, functional
groups of proteins can react with oxidation products of polyunsaturated fatty acids and with carbohydrate derivatives
(glycation/glycoxidation) to produce inactive derivatives“ supra. The role of unsaturated fats in CAWD
is significantly under
rated--another example of how business sullies science.
[19] “A two-hit hypothesis has been
proposed for progression of hepatic steatosis to the more serious non-alcoholic
steatosis (NASH), with the first hit being hepatic steatosis, and the second
hit being inflammation and associated oxidative stress caused by reactive
oxygen species (ROS) formation.” I quote
this because the role of ROS is frequently missed in the aetiology of NAFLD.
[20] A detail account of this process is found in
Dr. Jason Fung’s Obesity Code chapter and in his blog.
[21]
Various sources fail to make these connections, include the Wiki articles on fructose metabolism, purine, and their article on uric acid. So too does Robert Lustig in 2012, Fat
Chance, but not the YouTube series by What I’ve Leaned, Sugar Explained . Another example of Wikipedia unfortunate
reliance upon KOLs.
[22] This exclusion of glucose
from glycation of beta cells is not surprising for evolutionary reasons. “We
also showed directly that proteins in
beta-cells were actually glycated by using an antibody which can specifically
recognize proteins glycated by fructose, but not by glucose. Furthermore,
fluorescence-activated cell sorting analysis using dichlorofluorescein
diacetate showed that reducing sugars increased intracellular peroxide levels
prior to the induction of apoptosis” at 96.
I suspect the same exclusion in the liver.
[23]
See Fung Guide to Fasting, p 101-106;
the study done on the TV show the Biggest
Losers found that all but 2 gained their weight back, and one of the 2
had bariatric surgery, the other who lost the least weight, relevant
information is not given.
[24]
The elderly of aborigines lose weight with decrease in muscle mass, bone
density, etc. Men average of 7% and
women more.
14 The las t
40 years prove to exercise more (increases appetite) and eat less (not
sustainable). And low fat (high carbs)
and small portions with snacks between meals, fails, for this keeps insulin
sufficiently high that the window for fat metabolism is small.
[26]
Psychologist you to claim that about 2/3rds of obese will remain obese—and
might still do, the same figure given for the addiction to alcohol and
cigarettes. This fails because the
underlying cause is more than the stimulation of the reward centers like the
others, or the withdrawal which last on a couple of weeks. Years later those
who have lost significant
weight continue to gain weight. It takes
more than a temporary reduction in calories to repair the liver—see Section VII
on the fasting cure.
[28]
Pharma and insurance companies have worked to keep us focused on the lipid hypothesis,
as covered in Section VI.
[29]
Nearly every health association receives half or more their funding from
pharma, thus they
[30] A
further complication (confounding variable) is that those t2d who control their
serum glucose & fructose by avoidance of
carbohydrates and thus sugars fare better than those who rely heavily upon
drugs—2005,
2004,
2008.
[31] The most notable is Dr. Richard Bernstein, who in his 80s is a living example of that approach. The intensive diet program of Dr. Jason Fung proves on
a large scale the merit of the very low carb diet. Watch him on YouTube links
are on my video
page.
[32] The 20% who fail to have a reversal or at
least a major reduction in the use of medications that 20% have probably
progressed to type-1 diabetes, which is known as latent auto immune diabetes of adults
(LADA), and thus have been missed diagnosed.
“It is estimated that more than 50% of persons diagnosed as
having non-obesity-related type 2 diabetes may actually have LADA” Wiki
2018. Other sources place it at 10 to 20%,
which would be consistent with the positive results of 80% from bariatric
surgery patients, and Prof. Roy Taylor’s observation based on a trial of 10
patients. Not surprisingly, if it is 10%
of all diabetic, then for those who have had diabetes longer and those morbidly
obese, that number could be 20% or higher with LADA.
[33] Studies Concerning
Glycosuria and Diabetes, Harvard University Press, 1913.
[34] The high level of glucose of the mother with
insulin resistance affects fetal development of glucose receptors, and this
predisposes the infant to IR. Thus
each generation on the western diet has
increasing rate of CAWD--See
Lustig’s Fat Chance p 79-81
and Taubes Why We Get Fat p
131-33. ”This means that the higher the
level of the mother’s blood sugar, the more glucose her child gets in the womb.
As the pancreas in that child develops, it apparently responds to the higher
dose of glucose by developing more insulin-secreting cells…. The baby now will
be born with more fat” Taubes 132. This
explains the steady gain in weight of
newborns over the last 70 years and infantile obesity.
|
![](/imagelib/sitebuilder/layout/spacer.gif) |
![](/imagelib/sitebuilder/layout/spacer.gif) |
|
![](/imagelib/sitebuilder/layout/spacer.gif) |
![](/imagelib/sitebuilder/layout/spacer.gif) |
|
![](/imagelib/sitebuilder/layout/spacer.gif) |
![](/imagelib/sitebuilder/layout/spacer.gif) |
|
|
|
![](/imagelib/sitebuilder/layout/spacer.gif) |
IV.
How excess fructose causes CAWD
a. Introduction:
As shown in Sections I through III, the conditions associated with the
western diet are caused by fructose, and not refined carbs.[1]
The four ways I have stressed are the
diminished the production of collagen, hyperuricemia, hyperinsulinemia, and fructosylation
hepatic and cellular via the polyol pathway. In this section how these and
other effects of fructose are stressed. The body of evidence both biological
and epidemiological shows that fructose causes the diabesity (obesity & diabetes)
pandemic and by extension MeS
and CAWD.[2] The evidence is more than mere association;
the biological processes have uncovered several major ways in which fructose
promotes CAWD. Downstream of fructose
are many
pathogenic and potentially pathogenic changes.
Below is developed tersely those changes receiving significant journal
space and which are consistent with the major role of fructose, other I find
the evidence weak. For every major
biological process there are many functions that are affected: some such as
associated with nitric oxide,
cortisol, micronutrients, PYY, pollutants, and hormone mimics I consider not
fundamental to understanding the issues before us. Too many pathways and actors
obscure through
complications the main issues.
As covered in Section I, CAWD are rare to extremely
rare among
the elderly aboriginals[3]
and other peoples who consume life-long their traditional low-sugar diet (under
40 grams a day—32 lbs. year--all sources).
With few exceptions, wild fruits are both low in sugar and seasonal. A
second healthful practice of most of the LSP
is their not eating. While sleeping
(thus not eating) autophagy is turned on.
“Autophagy is
normally suppressed by amino acids and insulin” at 2009[4]. The western
dietary pattern of snacks and 3
meals a day contrasts with other population that do not get CAWD: they eat less frequently and skip meals when
traveling or working. Their major causes
of death in population with very low CAWD
are infections, communicable diseases, parasites, physical trauma, and
pregnancy. The case for dietary fructose being the main cause IR & CAWD is beyond being a theory.
b. Insulin resistance: As stated
above (see II c, d, & e), the de novo lipogenesis and fructosylation in the
liver causes IR and fatty liver. IR
by many is considered relatively benign; however, it isn’t. Insulin is
a major regulatory hormone that
affects many other hormones and thus plays key
roles leading to the diseases of western society[5]. Given the many functions of insulin (see appendix, Insulin),
it is causally associated with biological markers and a direct contributor to NAFLD,
obesity, t2d. The epidemiological
of
the CAWD to LSPs and the difference
is biological markers are strong evidence for the case against fructose.
c. Hyperuricemia
& uric acid crystals (gout) Having looked for some months
at the
literature concern the pathological consequences of uric acid, I find for a
confluence of reasons that other effects of IR act synergistically to sensitize
the patient to the effects of uric acid microcrystal and very possible other
effects of serum uric acid. Of those
likely to be significant would be the delayed replacement of collagens, mitochondrial
defects resulting in a reduced production of ATP with its effects upon cellular
repair systems, , low ascorbate. How fructose raise blood
uric acid and urate and thereby increases the incidence of gout.is firmly
establish. Also established is the role
of uric acid in endothelial dysfunction and nephropathy. Uric acid is derived
from the metabolism of
fructose and, which with excessive glucose causes gout, a condition where micro uric
acid crystals form, and when
sufficient cause inflammation, most often pictured as in the joint of the big
toe,
and can occurs
in other parts of the body and
form a tophi. By 2013 nearly 6 million
were affected. These sharp crystals
travel the blood and damage other tissues;
![Description: https://upload.wikimedia.org/wikipedia/commons/thumb/5/52/Case_30-top.jpg/120px-Case_30-top.jpg](data:image/png;base64,/9j/4AAQSkZJRgABAQEAYABgAAD/2wBDAAoHBwgHBgoICAgLCgoLDhgQDg0NDh0VFhEYIx8lJCIfIiEmKzcvJik0KSEiMEExNDk7Pj4+JS5ESUM8SDc9Pjv/2wBDAQoLCw4NDhwQEBw7KCIoOzs7Ozs7Ozs7Ozs7Ozs7Ozs7Ozs7Ozs7Ozs7Ozs7Ozs7Ozs7Ozs7Ozs7Ozs7Ozs7Ozv/wAARCADcAOkDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwAK5cwkbRmrtjcxGZrTbt2Dr60l06/MpTmQjLjtSwQbLsSMvRflI/iqj0WZepWodZZ50JCnEa1Mlsk0duwOQE+Ye9Xr25V7UMY8yngjHT3qFbVlt1ktzlhyfegaRlPazNO434UchfarotZH0gRwOAhb56ffmCNYTG2ZZztk/wBmrSWwsbdreF/OjA3Fh60FMx/JdLRYoVJgDfMacLWRrX73yucKK1I50OneTHHg7stmnxW6mBg33l5SmK47y4NMtTcSf6xU4HrXFzyNey75h/Fmup1SQXr2wQ5VThqpzWVvJdO8Y+RGAwKBos6bp5e2WYLhVHT2q5p+Wee6RdgjQqpPerhVfsv7sFFCbcetNEYGnxxJxzz71ImyKzsolSMbD5kp3ua1bexKIcHgNkU5E3eWqKA+Nrewq46lQEXovU0jKUhhtjIysvUCl+zEjB61YVcupjOfWpyi7CWODQYtmRcWG0hhzWDqlizqzrGWYdK6ydgo9ay5iXD44oNYSOStvtVq214yA1TTK4besZJxW2bTzSJJOgpLez892+UgA8UHRpYwR9rmhZfKOKrGGeJcbtpBztrs1s44n8snGaYNFjedpHIKYxzQLnicZJZXN5iWRuB0qCaynUbN2412MukpaxM8Tb+elZt2IkjWVmAkPG0Utik1LQ5O4t5w4wpyBWW7yrIWkUqU713CRpOpyozVO+0VZIGUpkn0pcxMoHItbQXMBB+8x61ENDDocyDParWp2FxZlXjHyL1FUWvy8Q2sQ5OMVqpXOeSsQDTI45XZm+VBx9aj81Kt3VzGIhGBnjJNZ3np/cq0Z2PYvNUM9rMCFbqatR3kexWjTd5AwMjrV82cNzid0wX7elZhuI4Lp1ePESnjHeszdMhmuCEFzJEFEhxikZzlIIW2PuzgdxU11Z/aImkmbajtuQelT6bbRzu7DmRFwDQXcyLqAR5lZcjf8x9KvafItvbyvEPMjcc+1SzQNPD9niXKlvnNT2tvHYzeQoyhHQ0CbH+XbtZLcRoOfvZrL1KRo2Hkt9a1rhFkhMKfIKw59rWvkjPmM2M0xpEUcAaCaZHKpFyc9zVuyt91sjeXtaY5B9aRLOWZEtWHlvjJH96tTTmJkSCYANH932qSpaFieNUiEMny4XrUKQtvj4/dhd2feprpGuopN33t2B9KsmPdaxQr0TqaRk2LZQttedzy3Aq5bt+4ZXGSelQxp520K21FNW0h8uNz13cChmLI7aURI6suMdDThIJYQSvAPX1qMgKojT5mPWnMAE2L2qbgkQO+N+VyO1V3VTgsuAaslXZAuOTUkdqQhMpwB0plehSaAFRGmctTktZokK9x3q4TGYi6uA69Kw9e8RRaXErSzBpCOFFK5pCLk7FqPCu3mHcw7ntThfWcZ2STAE8da4SPxBquqXhNrERG3Ga6HS/A95qB866uSuecZppmjpxjuX5b6xt22GdSGPrWDqlxZ3d4IrYZx0Yd66R/h/ZCM75m3juTWLeeFJtMmjltW81FOfrVLUUZxT0K1tAwKlsq392rTCXOCv1q0jssqS3cOzIwOOlMu0ki+eL50c1LsXzXMbUrRJVKhQxI5rzfVbZ9P1EsV2qTxXrEsYjGerMK4rxjZ+bAsiryvWhMiaujl45EmkOTwam8qGs2GRUbB61Z81fWtEzi57H0CbnEhUKNrDH0rLghSLUH80b4we9W4ELAK33sZqONQrMJf4mzUnQhzzxSGSBgNn8vpWfJciwnHlg4xgAda0btYY5g0S7i3TNENjFPM087bX24CUGlxlu5eyaRh5QJ4pxh8wgkFvl4ZalaN1iMMi5THWpYn8u3/dcgDGKZLaKkmYlVWBLjvWfc/vJI5Iox8rfNxWmWaVXdhwRjPpVG6ilj0YFDhnbqKCogzyS3DSL9xF696ZpayF7i5ckhPu5qeyKtaC3TJlcfMTVy3cC3FqsY3t1IpFSY+2SZ7dLxh8rcYNWQREpK8uRyO1QsJd8duDiJe1WrmMQyRJnJkNIxbJjhLSOMjDPzT97fIP4QaZKDJdjH3Y1xUkvyNt9RmpJGREgSuBznipI4y+1f4epNORRsx61KsTAxgd+tCJb0GGMNhhwEqle3yxfJ1B61JqF95AaM/LXIazr0NnE7SNlv4RSbNaNJ1GT+INfi061JDDzCPlUda4FFvfEGoCR8sc4C+lLFBe69fhiWZyfkz0FejeHvD0OmxDzADKeXPvSVztajSVupFo1jDpMKxyp++f7uK621nZY1Q8NjtWYYo3vxI4yI+lW0kUOWHOeRVHFUlzFm4mPJbnjFZ5m4C5+UHipZXLZJqlLICrY4IobsZxhrcldY5mCTqCmKzbtH0wq6oZbdzx7VZSXzMEnpWjYBLqJ4XUMPQ0bmjujmbtFkHnRDII/KuX1iLzbaVGxnBrtb62e1dxEuI+4rltatMYkX7rDpSaNotPQ8nlTy7hgexp3mewqXVIjHfyf71VuatHmVVabPoLzNrE7sHtUQka4kEmMbO3rUJYXG0IcletPdswFoSAy/eFB6Fie9YyiMgbWHQ+lWLXy3uFc5JC8mqqyfulLj7wp8cpV1jRflx8x9qBcpdvmO/OMxlaitSixbEGe9QLdrcMxVsohxVgORtaNcK3WmTYRot1uyKdpY9KzxHIStuzbkU/lVq+keGOSfOCRhBVG0nxdndk/LzQaJaFq0TNzIiDhR96poIzFNuB+bPSmRqsSNtb94xzV5o2ki85VGUHNDJbGwjzLlz1C81ZjiM7CctnDce1R6JEXjuJG6YNWYE2W+M/KTUsyZYii8zcRwc4NROSZCWXheKRXKq21u1NDMuSxyCKQrEpkBKhamNzhwR1AqkziJlK80y4l2wsw+81JjUbnPeKdYS33hzlj0rmPDOkP4s1J3nk/dRHpS+LI5N8jyEkdqzPBuvy6HqanrDI3zCpO9L2cLxPRl0S20mURwR4PY1abf5RVT8wPNa6vBq1us0WN5Gaz5U8otlSCOKs5VNz1kMTAQKzc9zTo/lJwd3pVYqycE5zVpJA4CgYIFANIVmPc49qq3BG0rjG7vVqROOeTVaUZjZH6gcUmKL1M7eUlEYOR3NbGnzrHcxoDgN3rD5ANS205DgoclDSTNJx0Oi1NASSwyCK5LWbdWsmlHRRjFdfdI01jFOOyciuY1Ab9LmZhjNUzGn8R4xr6bL361m1s+I1Hm7vesTdVIwrx9893hVLLJB3MRzVRN6ymRG+Rm5FRwSsG2HJTHWnwnzv3TDagOQahM9CxoyCRsK67UA4Ip1pEfNyj5BGCDTWLPtG8FVHNKXxIpXhemadybkkdvHbROy9C3NEUxklELEpGehNPdFKbd2C3SkI3ForgYbb8jD1qkToZOt3EirEY2Loj4HvWjZJvtmbYPNlxiorK1LyzJMQUUcZ9ansFkW4aNGyIuQaY7qxddY/tIKqDtUZFDymDOH+//AA1GBuvC3SXHHvVeG2mnuHY5baetDZnoa9kwg0uQjIMjcVPECqpD13c1FAQyFSMLGMfjUkSnMb/xfdqGZskYBGcMKZM4FuAB81TMFiZy3JX9ahuyBEpP8Qz9KATKkkhChhyBTGl8yGoHfKuQeKbbS/aF2Zx6UjXl0uYfie0U2hPUkVwOnR4vkXGTvxivRddjbyyGOQAa4bSnSDxJA0i5QPz+dT1OuL/dnqNgZ9Oto2jB2FenpW3a3lreQhZlG719auw21lewRyIBjZ0rBvbZ7O5MqcKDwvrVbHnqSk9S/eadG6b4W+Ydqq/ZmRRuGD60R3e8b+Q3pUjXEtzGS3AUYoG7rYrNMwyoGcd6q3WSgORzU8lrL8pVuG61m3SOgbDZAoZpBJlZ5VVzETyaLOJxKVHBJ61iXdxKLlT710OnfvEUyLxjg1K1Z1TVonVK+NBcYyQvBrlNVbboTEHqDmune48nQ3KqFAXAzXnuoamDay28hw4U1bOSmveueda+Q4X1JrG8o+laOrS7pF9QapfaW/u1SMqtnLU9cMrRqkYGMirluQ9uVOMY6+lYyTSqVlmBIXgVYkuNiHyyVVuSKix3GlA8caiFWLMx5NXowHf7MB93nNcsssjSbotwwetWhe3cEgcsRkdaaQcp0Fy5SVEYEqvIxUqbnlEn3lHrXPx3V7NLlG345xSm81O3dswsAfQVRDpmwzyqzyLgKD09a0LVANNJ4Ern5j3rmbfW5Yf3dxBwOc1q2Oq2cxYeaef0p2IcGa0Sh0CkZlQYyO9Twhba2WBeXbJc1QhmVd7xybmJwtWZ7ecbOfncjNJmTTRPaZmkEYHU5ariqBcM3RU6e9JbIIHO0fMRg1YESeUwduR0FSZsY3l/fftyfes2cs26RuUJ+UelW9xCtvXKjpVWZi0fyDgmgI7mMGbzp4umFyPeqGi3LT6rJDu+WOtG93RSLKBz0NYFjOlt4nkgjHEgzSW53xjeJqa+cQMa47RbFrrWVyvAbmuw1OCW5zGBkZqPR7RbW6LMmCaVtTSFuRo7XTJBbqFB4AqxqkAngjm25OO1ZcEmB7VtLN51ngdhjFUzy5K0rnMsWtbre2CjVYRw0uAfkaor+Jg2GXABqO3ZWz82OwoOhaxNS4VVjVVPTtWFfYGQv3e9ar3JVBEi7pPU1hanvCvyQ5/hoaCmveOev5ALoLjj1rc01w8UeWxtrmbvzI3WWQhif4R2rZ0STzlwpLAGpjud1Re4dDrkrDS7ZMsEkkG7Fcl45jtTKn2NSu2P5m9TXV6iQxtYc5xyRXJeOrhUQJEmC3WrZxxVrnmF83mXCqBkgVH5cn/PM0l2+LklDgiovtE/981SOOctT1WO5LqzPH8kfWo5JgxViuFPSrWnQy326CRcKew61HNYyQSyRSqdo+4abR6XUri5mU8keWTwcVoRbLghZhwB8pqlDFukSH+9zg9q1jGylY2UfL3FCNNEiCF109ZZ9hJA4FY0XjrUFmkaaANEh+7t611zWlpeRiO7Jj4yjDoa5+7s7PRNQRZI/NtZzh2x0pMlO5pWlzba7pv22GIIT1X0qvNYrEm+E4H8QFVvBsE1veX5jybZSSqHuK2buI2s3mggxyc7fSnFgyHR45WukBY4UZ5ratZb43ZuWO5OiisqxlTzGkZtp6AV0GmIUTy3PfihmFTRXJINSmhkZpI+KtR6ja3Pyu2xqkeCPHIzxWTdWKEluR6YpHNFqRrOyvGURgRVF8xZUHNZDtdWalkckDsalstUiuWCynbL71LNFC2o65cFWDD6Vwj3H2bxShY4JavQbsD+IAEjivPvEcSRXizHh93WoWjudlN6WPQYoUZBJuySKSKzYuXYdDxVLQL4T2Me7sK3IMyE8jFXbqYSvEFjY4AHFX7Ntrqh9ah27B1qSzxuLfxA1JzSvYXXot7qqLgY5rAfZBIpjHHr711WpOjW+9cFsc1yF9cLFayH7o7Z9adyqTb0JxN5bGSTmTtWbrN2CR8waSQYwO1Mt7ySaLL/AHccmora1824d2O8DpWiR1qHKcjqKT2kzbt23ruNbfha5UAkHIJq1raq0czSou1VwK5fQbzyJ5YoySWOAKzcbM3crxsehb1e7e4zu8pelcJ4suWuA82cd8V02pX/APYeg4bmaYZyeted67dyTWgJbBfnFO1zlfuo51XRi7OMsTR8v92mMPlHHSm7x71SOCS1PbzaXIVltRsumPGeOK0zYt/Zvl3WPOVCd3qamv4ZL22jnSQQywdAO9PdJJbBZ5R8qjH1pnTzu5zEUP8AobGRQrhuG71YNl/qXtbhpmPMintUu6AXADjdn+H0q+LU6epkgG55hn/dFBvzOxW1CzU26RrKXb7wA6L7Vj6lC8luPMUtjgLXV6UtsIpI2w7kZOagv47YQYJG7NJlxlc5yyM0N3G9uNpwMjsa270QXFsJ42zKeCnvWajILKafPCnAqOCXaBPu6cj3o2NVC5n38ksEiYypByRXX+HNUW+2b+GxXJapO0xNyVyo6inaRqgt2W4hb5QenpWbYVaV4nqJUMfaqs0YwcCmR6qj2cd0q7kI5xTUu0u32x8r1zVJnlODgyrJbqQWf8q53VLFkYTxfK2eMV1krDdyOKyL7HKt3p2ubxehkWeqy7St9yB0Nc34lnjmljKcrmuohsVkVjIuU9K5LxDZPp2oo7Am2boPSokjrotXOr8KOlxpwA4IreVnjkC+lc34HkiMb+Z8qH7tde1qT+8XBXsatbGNR+8Lbzb5MNk1eQKys0XGOtZ8JCMre/NaszLHGpiG0P1qUc05alQyCU7WfG3k1xWr6nBrLSJbnZHayYYjua6u8jQM7M207M1w0s1jEzQWsJAZ90h9TTSOqjFWuaNuA8COowr8YqF5ptPlkWMFy/QelTWWpQAFdo2oOKSK6jluJLnYFz8qg1rsW4u9zG8Qi6a3EgJIkHzD0rN8H6eZ9ZMrD93Fyxrp7608tjDI4feu4GqVjKmnabPKibVbOT61LRV9CPxZcx3ysq/djOAa821K4Es5UNkJXRatqf8Ao7lThWzxXJZByT1PWkctaWgihmDYqPY3tUuz5cKcUzyD/fpnI7n0RcnyHjXcH39MUy9kuJ4S0TgQR8OtQSz/ALxsR/IvQ+lRzXCrAQuQuc/71FzqUHcpGJnaRo1yVGfek+1TC1Bml+ZhgLnkUv2iUW00gxGpPLVkRqd3nNIXJOADRc6lFWNbSJPOunjkm8pAvUnrTNUuInulhtWJVPvE96qo8YjckfMKfFBuj821AeVuqt2pD5UtiWOJYrF1cZWXoKhtoXMbQyqRs+7Vy1gexVrrUjlF5VV9aklvrSWISrkFugoBTaOe8mdrhbfqrON30qXWPsGla1Da2o3ROo8zHY1YtYpFujMrbt/Y9qvJosTTiWRNzHnJqOVlOp3LelTS6TNG0n720kH3fStqNl8uR7Zdqs2RVWK2Qw7MDaO3pSmZ4oSIhnHaqtZHLO0noWJpv9HLMcFa5v8AtV7u+MKIWUdTUF/4hAmNrc/u1PGRWpoFvY7S8EqyM3XnmhSQ3TaRow2zPCMja2OKwfE1lHJoVzI+D5X3frXR7mklwWEajqW4wK4zx1rdu0a6Tp7bxn944qZu6FSUuYxvC+ptZ3K7zuQ/w16vpw80I24lZBwPSvE7fMMse372RzXrvh24Elkp34YgZpp6G+Ih7uhpyL5cjx/LioZbjzFCpnKiknkUSsxIzWdcavbWULtI3zn7oFByQp3Womr6h9nsHldl8zGADXDobq5DSQx7nJ5wO1a1+015GJ5lxGTwPWtjwr9lRZ4nRFJXgmhHZbljoc4mj3s9q0vMcQHJqpY6mIIntZDuZW+U11eq6raW0bWAf5G+8R2rgZzGLsmE/Ip4J71dyldo6Ke/aWaO3HzPjg1R1y+/0RbKIYA+9VjRY1iglvZmyxHy7u1chrWpyS3Eu3gk9qdzGbsZOoSvNJsX7qVVljURhx37UoZlBJOcnmk3ZOW+7SOKTuyMLuXg4pvlP61OqryTx6UbWoJsj3QyN5bHHyNVSSUS/ux0QUjT77JyhyoNRyFFQMuRuHNSd0TOvJ3uAsKHaiH5verEdp5Ua3EnHPyrVaKMENMxyqnp61ZnkmlSKVhwp4UelBoOnt1Miuq8HqKjjgLzMYZDGAKt3F8mxIkj/eMPyqtepNbwgpgSN1phqS2q3LFrS4k81H6ZqW3tI5F2ZGQcAVXsmmwrSSKGPANTQSxW7yB5Avue9ArFuG0igLOxyR0FXBMZYVbAUCsObV7ePAikEhJ5qBtWuL2QQWcL7m79qRLR0Ru0iOQwZe/NYt/4k2sY7FDJIeNo7U1tC1GfK3U+1e4U81fs9Ht9Og/dx7n67j1pXFocyNKmk8y+1RjknKpWAmpXVlqrXNlK0IU42nvXc6hqSQXaBo/MA5I7Vzlzos15qUlyIwqP8ygDilY1W2pM19resR5kmMasOo4qn/Y0qAhgWkP8R710OmApFslHCcYrQtrZ5Jh8ny54oaBOMVcxNH8LsSJrg/QV1lraNbxkRnaO1XorMKo3DAqaSNAAc8DtQjGdTmMyW2mf5jJxWXBp0VzqfmXL5jj5xW3K2EI7Gsq6tHj+eJ/vdaYR0Qa9JDIiC3wEXnArnpJpIGMschBHJwa35YIfs4H3nxzXPXlvJHldwO7t7Uzqpq2sile3yyq3dyM5qnYadPq12kaArCDlnq3baVNfXQRFKp0LGtO9u4PD9g1rbkE9z3zQgqSXQreKtSgtbGPTrb5XQfORXBO/nOXPQ1cv72S7leWQ5Z+tUtpOccCqOKcrleXrTQC2ExUjAnPFNG4EbeTQc9tSZgrR57pUX2z/AGacQ+Qp4z1p32eL1FAWPWlbZGsa8L3qRoAYx+86iqunXUd3aiR2CjuSelU7vW4ILl7a3zPL/CBUnatC0iKA/IVV6Z71De6tHb6eZWdSy9ApqnDpuqav/rWNtGD9wdxW3b+G7JGQyW7SAdST1NA+ZGVpurzXH76O1aQ7eCRTwmu6ldELCAjcc9q66AQ2+YreBVUjGMVOIZYE3R4Ut2FBPtDlLfw1fwSeZe3GADwgNTxeG/OkkWWdmD9P9muge3UqWlkLSdqchjxgHYpHJ9aCfaMztP8AD2n2igMm89yasRrb2M263iAAPpVl23BVVtoH61GYDLwRikxc9xwJnuWuCeD2pl2zR25weT0FTpGIVCKNw70rQCZ97Dhe1SS3rc5+TTCbSWVuZCM1Z09PN0+MgBgpwa2HjULwmVYYNZ2mxiwv3s2OYpTuUn1p3NPaXRattHjlYuOPatOG2RMBV6U9U8mTap4xzT4pNgyBnJp3OdyY1yzHbtxVaeLHU1dMjK26RcKe9VJ23bivIqbkwvcz7o5TaKbBGpTD81JLGWXngmq1q7eeyD5h39qpHS3YguLR4SXj5BNFtpEMuZLj/WN90VqLhYzu57VX1K4jgtSwYDA4qg9q5aGTrF1HpWntGiKG7Eda801G+M8zSFy2fWtfW9dNxO6H0wK5pzyS3NAN2RG3PzHilzvULSf6z2xTolZ3IxxSM9yKQkHywOvenxqsX1qcwkfw8014D8vYmmiWhhVpPmbpTdiVM4EYwTkUzfD/AHqYjd0Ky1PW7nyxvWJjzt7V6LpnhnTdJhLbfNnzyzcmsbwtp+oRWe2MeW4PJNdlDbeQmZG3k9c+tCNJzI/3ds6i2jyxHIakEkzOchUA5YGp1gE0m9327ehFRmJ5WbzMBAeo6mkzNaixSIAzhRg9KaJ3VSfvA9KdHbpGDlxtPQUjosSEqfwpDIhyhZug5zSIfOb7uBjpS2qtKxDcJ2zVookQ3DGe+Kkoq2q78tNwFPFSuwM4PQY4FEaeYwD8DNLPGrTjH8NILgMA47mryRA24A+9nn6VRUD7x7VaguQRkcduaCWLKgQ7cfLWNrEJEHmJxLGdy1uyofLU56VUuollTew+UjBpig9SrY6it7aLLu/foMMKvJMFAD8Fq5eRho2qRyR5aCY4b2rcF3AV5YMOqmguUbmi7g4UtkVG+1c+lRI6lQ4+Ye1G7cSx4FBFrMrXUm7DLwAKpWTfvmbpzVq5cFH2joapW8iC6VMjbjJoubWujUmdIlJfgEVwPi7XkTNvDJ+Rq14r8VIpa1hbLDjivP3drlzJMxLZphYaxZm8xjkmojl6kKlnwOgp0cZfmgVriRoAOauQxqBnHNMSGraRBVBpopRK8g+aorhSVDZ4FWZStVpX2xOW5HamSylMxK4Xk1X8qf8AuVYYnCtGpqTzJ/7tWkYs9vjEjW0YibHrirOJEKbxncMGqUdwywYEZU54q600jQ529eBUMJDZpGj2xdF9aQpIzHy8sMVPGUWEo+N49ajimwxB7+lSERywbQrzdR05qJpWeZspn+6KJMu2XJAHSnRyLwQvzj7tIYse8Nl12j0pEcFm7+1MkLPNvkkAx1FBdTmaMZCdaCiViFQuDj39aYm7Jc9/0prukgQMdoboPSmyzKqBFPTqfWhhYW5mCgv6Csiz1zzdS+zuuEPQ1Yln3sY+uapSW8cQ3hcSA5FSbKF0dMJWyVc8D7tOMgaIqRyazrK5W8hG9sPGOamScM/oM1Ri42ZWuraNidy5rNulFlAjRqTuODWvMu4Md3Ssy9kBjEWQSaDWO5c055lYBZcrjOPWrskof5R/D1965iC6MJVlY/IcCpNU8Q2mm22/zQZPTNASjc0tRvkhVnZwgUdDXCan4oIWSCz/ANY5+9WTq2u3WrTH5zGh6c1mrwNo+9/eosC0VhWeSRy8jZlPUmkKEnj8akihJOScn1qykPHPWgCskJNWoYgPlNSrGAKcqc5oLsSpEkYzUErjcfSpXGBVWVSTx3oBkM75GRVN5JHG1TVxk2MFbvVd/wB3Idq5wapGEmNaXyowpI3Go/Nk9aZdyoWU45pn2j/ZrRMxZ9AmPKlMDZ/epIlkYbc/KDwagimdlKE8UsMrk+Xn5c1BRYkcMQm3Ln+KmxxeVIec0Id85Q/dFV0ld7mWNjlVHFSBPId8mM5FN4MnBxtpwUCJT3qCXhsjvSZRO/lyYOOe9MQq8/lj5Y/4hTyoVUx3qKRQokI9KaAjuMM7lOR2qCR0MeAfmXtUe9lMYB6nmoyP9IekaxGk7Cp6n1ps1xwRtye1TRqGDZ7Cqb/dY981Joip581rMHViFJ5FbEOpwSKBuANZMnzRtmsi7Zo2JUkHFBTR1Ul+CxUOMH3rG1C/iWUfvANvU5rl57+5UHEhrLubmZ1yzklutNEvQ3NW8RJHEY7bk+tc5JNJdNvmYsT2PaoenPc1PCoJGaZi22xVjLEe1TxWxPB6VNGi7hxVyNFz0ouaxWhBFbgcVOkIxzUwUZpH4bAoNEkRBcUmNxAHSnNTgMRqaBEU5CsF60xsJHk9aSX/AF4qK4Y7iM8UEMjlbc4bGcCqbo+8tnANWEYk024OJMe1UZSKbhQuWGTmm+ZH/dp1x/q1+lVaoxZ//9k=)
of particular concern are the epithelial cells
lining the arteries, capillaries and nephrons of the kidneys.
Diabetic nephropathy affects
over 6 million people and often progresses to end-stage kidney failure. It is
a common among those who have had
diabetes over 20 years. Uric acid
is the major driving cause THewre is a synergic relationship to defective
collagen to which uric acid promotes, turning on of the polyol pathway with the
subsequent fructosylation, high osmotic cellular pressure, hypoxia and
defective mitochondria. All of these are
present in the type-2 diabetic. Further basic
research is needed to measure the significant or uric acid crystal upon the
kidney for those with late stage IR and
also upon endothelial cells lining arteries.
Damage causes a viscous cycle since the kidneys are the principle method
of elimination from the blood of uric acid crystals, and with damage to the
kidneys the rate of excretion declines.
These crystals also damage endothelial cells lining the arteries, and
since they are the gate way to in the interior of the arteries there function
as gatekeeper is compromised in ways that promote atherosclerosis and therefore
CVD.
Consistent with the increased consumption of sugar and the diabetes
epidemic “Rates of gout
approximately doubled between 1990 and 2010” Wiki.
By 2013 nearly 6 million
were affected and increasing. The causal
role of excess fructose and the subsequent elevated uric acid and t2d has been
established in a seminal
article—Oxford Academy 2009.
The belief that pyruvates from
meats are the cause gout--once for decades accepted--is lacking in compelling
evidence (see Taubes supra p 238-249 for the burial of that belief).[19] “Fructose
also inhibits the excretion of uric acid, apparently by competing with uric
acid for access to the transport protein SLC2A9”[20] Wiki
2018. “Dietary causes
account for about 12% of gout,[3] and include a strong association
with the consumption of alcohol, fructose-sweetened drinks, meat, and seafood.[12][15] Among foods
richest in purines yielding high amounts of uric acid are dried anchovies, shrimp, organ meat, dried mushrooms,
seaweed, and beer yeast.[16] Other triggers
include physical trauma and surgery. . . .[4] About 10% of people with hyperuricemia develop gout
at some point in their lifetimes.[14] In purine
metabolism this interference [by fructose] has a dual action, both increasing
the conversion of ATP to inosine and hence uric acid and increasing
the synthesis of purine.[19] ” Wiki gout 2018 and also.
The old belief that
gout is a sugar disease has been confirmed.
Gout is like hypertension a sign that there is some very wrong on a
cellular level.
The role of fructose and uric acid crystals in the
pathologies associated with CAWD is based
upon diminished kidney function and endothelial dysfunction. It is more than
theory. “Under
excretion of uric acid by the kidney is the primary cause of hyperuricemia
in about 90% of cases, while overproduction is the cause in less than 10%.[4]
High intake of fructose contributes significantly to hyperuricemia. . .
. . Fructose also inhibits the excretion of uric acid, apparently by competing
with uric acid for access to the transport protein SLC2A9”[20] Wiki
2018. The risk,
however,
varies depending on the degree of hyperuricemia. When levels are between 415
and 530 μmol/l (7 and 8.9 mg/dl), the risk is 0.5% per year, while in
those with a level greater than 535 μmol/l (9 mg/dL), the risk is
4.5% per year”.[11]
Wiki
2018. I maintain that a cofactor is the degree of
insulin resistance. “Fructose
rapidly raises uric acid . . . . Lowering uric acid in fructose-fed rats
ameliorates much of the metabolic syndrome,” 2006. “Uric acid causes hypertension, atherosclerosis, and ischemic events, through several pathogenic
processes. Among them is the lowering
of nitric oxide (NO)”
“.
. . many
aspects of endothelial function and
occurs not only in the kidney. The close linkage between
micro-albuminuria and endothelial dysfunction in diabetes is an attractive
explanation for the fact that microalbuminuria is a risk marker for
atherothrombosis” Clinical Science 2005.
“Asymptomatic hyperuricemia in humans is also associated with
endothelial dysfunction (107)”, a seminal review 2009. Endothelial dysfunction probably occurs at least in part
from the same processes that cause glomerular dysfunction in the kidney and by an anti-proliferative
effect which would include ROS
and other pathogenic modalities, see 2005, and 2005. The
formation of sharp microscopic
uric acid cause abrasion to the fine structures in the kidneys, and I suspect
such micro-crystals, damage the endothelial cells lining the arteries to promote
endothelial dysfunction, and thus atherogenic.[6] The damage to glomerulus result in reduced
clearing of uric acid, which thereby promotes the formation of more microscopic
crystals that further damage the kidneys that can progress to nephropathy which
would cause hypertension.
This
role becomes pathological with
other conditions and life-style factors besides excess fructose
consumption. “Alcohol consumption has
long been associated with hyperuricemia and gout” as has diabetes and insulin
resistance at 2002. Thus a combination of
factors all associated causally associated with excess fructose works
synergistically to promote CAWD,
most starting with excess fructose.
This
leaves me with one last
question: Why is gout is virtually
unknown for LSP, yet unlike other
makers, such as for insulin, serum glucose, blood pressure, adipose tissue,
that of uric acid in the Kitavans and healthy Swedes have only about a 10%
difference--Lindeberg et al 2004? (I couldn’t find measures of uric acid in
other LSP). However, a subset
of about 10% of the
healthy Swedes have significantly elevated uric unlike the Kitavans for whom there
were none. This subset of elevated level
correlates with the incidence of gout. Unfortunately
the study by Stefan Lindeberg doesn’t follow to find out the long-term
consequences of the subset of Swedes.
Based upon the Kitavans it appears that the level of uric acid that is
considered normal of those on a western diet is not pathogenic in itself; but
is when the population is on a high fructose diet because of their other
factors. That health Swedes are only
slightly above the level of uric acid of the Kitavans supports the role of the
afore mentioned other causal factors for CAWD.
Science is a long way from putting
the pieces of the puzzle together (see journal articles pasted at Healthfully
uric acid.)
In summary: The role of uric acid is complex: it is not
associated with
pathologically until IR and NAFLD
are present, at which point the
ability to handle the stress of uric acid has been compromised. Then the micro-sharp
crystal form which damage
endothelial cells and kidney cells. Other factors such as the underproduction
of collagen, compromised proteins due to fructosylation, and reduced production
of ATP by the mitochondria could all function synergistically with uric acid
crystals. Thus though the level
of
uric acid is only about 10% higher for the healthy Swedes than the Kitavans,
the ability to handle uric acid has been compromised, 2004
Lindeberg
(an explanation Lindeberg doubts). There is no doubt ”that excessive fructose
intake (.50g/d). . . . There are now extensive experimental and clinical data
supporting uric acid in the pathogenesis of metabolic syndrome” (Richard
Johnson et al, 2009,
seminal article) and much
more.
d. Fructosylation and cytotoxicity: Tissues
with frequent pathological developments
in those with t2d are the kidney,
retina, neurons and related cells, and capillaries, arteriole, and endothelial
cells, thus an examination of the literature on the pathology and abnormalities
involving these tissues is often fruitful.
Like much of the journal literature seminal articles are off not
available; an example is the basic research on fructose and
fructosylation. I have yet to find a
seminal summation article; thus I must proceed with articles each of a limited
scope, and also interpret oxidative stress
as a result of end
product of fructosylation where context
supports this reading—few
researchers are aware of this process outside the liver. There test for glycation
is based mainly on
end products of the Milliard reaction, which occurs also with fructose, and
given it 10 fold increased reactivity compared to glucose, that is sufficient
reason to consider as very possibly why it is mainly fructose that is
responsible for overwhelming the repair system, and this is one more pieces as
thy for CAWD.
Allow me to restate
this: the role of pathological role of
fructose is underestimated for 2 reasons.
One is that the testing for end-products of bonding by sugars is often
grouped as glycation, rather than perform further testing for the bonding of
fructose to proteins. Second many
researchers knowing that the blood level of fructose is much lower than glucose
assume that assume that nearly all of fructose is in the liver, thus no needs
to test for it; they are only dimly aware of the polyol pathway (e below). This
is further compounded because of the lack of awareness of the toxic nature of
fructose. Moreover, the current testing for
HbA1c doesn’t reveal fructosylation at 1992 and 2013.[7]
Too often research is done with the
goal of
finding a drug.
When the glucose levels are high, a
significant amount of glucose is converted to fructose in the polyol
pathway—see e below. This has been
shown to significantly contribute to fructosylation of proteins and other
suitable substrates such as polyunsaturated fats. This is further complicated
in that several
tissues take up fructose directly from the blood plasma without active
transport. This includes the kidneys,
eye lenses, neurons, and the endothelial cells in the intestines, thus making
these tissues more vulnerable to fructosylation. For neuropathy elevated levels
of sorbitol
and fructose have been reported for diabetics, and “the most common
abnormalities were fibers undergoing axonal degeneration” at 1980.
Among the finding was that fructose-modified-HSA (human serum albumin,
the most
abundant protein in human blood plasma).
It is an important marker for diabetic pathophysiology at 2016.[8] Similar finding for bovine serum albumin (BSA) are widely reported; e.g. Oxford 1993. Biochemistry 1988.
The same can be expected for other proteins and other receptive
chemical including polyunsaturated fats—see section VI.
Fructose being more reactive (in the endol
form)[9] undergoes glycation with
proteins (amino acids) at 10 times the rate of glucose (see II b above) in the
Maillard reaction to from mutagenic compounds and play a role in the conditions
associated with CAWD, at 1993.
Because of the intermediate and end products
from by fructose’s reaction with amino acids, its role in the pathologies
associated with t2d has been grossly
underestimated “Compared with glucose, fructose increased the fluorescence
intensity and the cross-linking of glycated collagen, and promoted the
polymerizations of proteins… accelerated the production of advanced glycation
end-products more than glucose” (Experimental
Studies on the Role of Fructose
in the Development of Diabetic Complication, 2002
and 2003
on the contribution of the polyol pathway to t2d through oxidative stress.
e.
Polyol pathway
produces sorbitol and then fructose thus cellular fructosylation
![Description: https://upload.wikimedia.org/wikipedia/commons/thumb/4/49/Polyol_metabolic_pathway.png/600px-Polyol_metabolic_pathway.png](data:image/png;base64,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)
The
polyol pathway is a 2 step conversion of glucose to sorbitol (an alcohol sugar)
and then to fructose. It is turned on
when within a cell there is excessive
glucose,[10]
can damage (toxic) the cell by excessive
osmotic pressure—see 1990. The polyol pathway is a quick way of lowering
the amount of glucose by conversion to two other sugars, in a two-step process,
first to sorbitol and then some of that to fructose, both of which can be
further metabolized to produce the energy molecule ATP. For LSP the frequency of the production of
cellular fructose is a fraction of what occurs on the western diet, thus
fructosylation (also grouped with glycation) occurs sufficient to contribute to
CAWD.
Certain
tissues, the retina, kidney, and nerves do not take up glucose by the GLUT 5
transport system as this system is missing only
in those tissues, but rather glucose is absorbed by diffusion across the cell
membrane, thus that tissue will absorb an excess of glucose when it is very
high in the blood. Turning on the
conversion of cellular glucose is a quick way of lowering the excess glucose
and avoiding the consequences of high osmotic cell pressure. However that process
doesn’t work right or in
excess thereby creating intercellular pressure, which happens at a higher rate
among the insulin resistant, since the starting point before eating has higher
level of glucose, and even more so for the diabetic. Among the diabetic the
tight controlling the
serum glucose has in trials failed to show endpoint benefits, and the degree of
damage depending on the drugs used.
Moreover
the end product fructose present problem similar to that for hepatocytes. The
missing of the endogenous production of
fructose enables pharma to stress glucose and slow management. The polyol
pathway has therefor adverse
synergistic effect t throughout the body.
f.
Low ascorbate in the polyol pathway “The pathway is implicated in diabetic complications,
especially in microvascular damage to
the retina,[2] kidney,[3] and nerves.[4] Wiki. One issue arises because diabetic have
low-level of ascorbate in those 3 tissues and the others which store a high
level of ascorbate,[11]
thus the lower level of ascorbate in diabetic could be a major contributory
factor for the microvascular damage of the retina, kidney, and cause neuropathy--see
1990. One pathogenic way is in the glutathione-ascorbate cycle
which
“detoxifies hydrogen peroxide” and other reactive species-see Wiki. Thus diabetic given their low-level of
ascorbate would likely have a low-level of glutathione (possible the most
important of the body’s antioxidants) which is need to quench the ROS including
from the fructose produced
in the polyol pathway. The lower level
of glutathione in diabetics would promote damage from fructosylation. This lack
of glutathione explains why
diabetics suffer from the effects of ROS.[12]
g. Osmotic pressure from excess
sorbitol, glucose and fructose, These sugars are hydroscopic within cells, and thus an excess
cause an influx of water. “As sorbitol does not easily dissolve across cell membranes
this increases cellular osmolarity, ultimately leading to cell damage” Science
Direct. The level
of sorbitol is controlled by the next
and final step in the polyol pathway, the synthesis of the reactive sugar
fructose. Thus we have a protective
system, one which lowers intercellular glucose and thus osmotic pressure in the
vulnerable tissues (kidneys, nerve and retinal cells which lack glucose
transporters) gone wrong because of afore mentioned issues and likely other systems
that are functionally compromised.[13] The same functional issues, but to a less
extent; I aver, applies to those who are insulin resistant including diabetics. There
are reasons why osmotic cellular
pressure is regulated and this in part explains why cells become Insulin resistant
through a feedback system that prevents excessive cellular osmotic
pressure.
h. LSP
on high carb diet avoids CAWD, why? So why do those peoples on a high-carb, low-sugar
diet not at the same risk levels as the TOFIs
(excessive visceral fat but of normal weight)?
Their polyol pathway is turned on like those with TOFI when there is excessive glucose in
a cell so as to lower the level and thereby lower osmotic pressure--2000 and 1977. With TOFI,
they have developed insulin resistance, have fatty liver compromised liver and
kidney functions, and thus are metabolically different the LSP. TOFIs are producing cellular fructose though the a
safety valve
that works fine among LSP who are on
a high carb diet, but not when fructose is excessive and there is IR and fatty
liver, as a study of rats feed
a high fructose diet demonstrate—see 1990[14] To this we have the
other compromised cellular process associated with insulin resistance and
diabetes including underproduction of collagen.
The detail as to which of the many effects associated with IR are most
important is in need of
further research.
i. Under-production
of and oxidative
damage to
collagen: Collagen is the foundation protein for many tissues:
there are 18 types of collagen and they make
up over 35% by weight of the proteins.
The high sugar diet affects the production of collagen in several
ways. Attention to collagen occurred
when it was found out that diabetics are vulnerable to the effects of lower
ascorbate;
which as a co-enzyme affects the production of collagen. Other contributory
factors for diabetics
include the elevated uric acid, abnormal
mitochondria causing lower ATP production, and reduced cellular repair
rates for ROS. All four just named—and
likely others--reduce
the synthesis of collagen.[15]
These changes affect the function
of ascorbate in the production
of collagen. This is through the hydroxylation of lysines
and prolines on polypeptides.[16] Among the suggested
causes for this under-product of collagen is the depletion of NADP in the
polyol pathway. Though the research
is incomplete for
want of funding and faulty causal models, there is sufficient evidence to
support the conclusion that that lower production of new collage to replace
older, defective collagen is a vector in the comorbidities associated with
diabetes IR and CAWD.
An assortment of pathogenic
consequence has been
obtained experimentally in rats (Diabetes
Jan 1989. “Diabetes
induced a greater defect in collagen production than food restriction and a
greater decrease in collagen than non-collagen protein production within each
group, suggesting a specific effect on collagen”[17] June 89 Diabetes. “(1), decreased bone mass and rate of formation
(2), and thickening of the
vascular basement membrane, (3) Abnormalities in the connective tissue of one organ
may in fact be a signal of more generalized defects, which are seen in patients in whom increased skin thickness was
correlated with an increased incidence of retinopathy
and neuropathy (4) and in the limited joint mobility syndrome, which was associated with an increased risk of microvascular disease (4,5)… the widespread nature of connective tissue
alterations in diabetes suggests that abnormalities in collagen metabolism may
play a role.” at Diabetes 1988. See also Diabetes Jun
1989 and following on “endothelial dysfunction” and “bone fragility in aging,
osteoporosis and diabetes” at link. Collagen
defects are the big piece in the
puzzle that explains the wide variety of conditions associated with the high
fructose diet.
j. Fructosylation
occurs to collagen. The
need for replacement collagen is increased because of the much higher rate of
glycation by fructose, compared to glucose. This ”leads to the formation of advanced Milliard
products in the polyol pathway” at 89
and 2002. Since the polyol pathway produces fructose
throughout the body, this production affect collagen throughout the body.
In summation I hold that the
association of CAWD with elevated
glucose, which occurs among those who are diabetic or insulin resistant,
because the polyol pathway is turned on to lower the level of glucose and thus
osmotic pressure and as a consequence fructose is produced which results in
fructosylation, and thus it is not the glucose but fructose that ultimately is
pathogenic. More research is needed
because the extensive research on collagen during the
golden
era of medicine is now a
trickle replaced by the search for marketable drugs. Clinical trials of ascorbate
and myo-inositol
supplements for diabetics are lacking.
This hypothesis is made stronger by extensive evidence that fails to
support a significant role of glucose in diabetic’s associated conditions—see section, VI. The failure to follow up with a study showing
the benefits of mega dose
of ascorbate or myo-inositol for
diabetics is one more example of the role of pharma in the practice of
medicine: standard of care is to threat
diabetes with patented drugs that lower glucose mainly by raising insulin, a
practice which harms patients. There is
a need for research into the level of ascorbate in cells that accumulate it
among those with IR compared to
those without IR, and also to do
studies on the quality of collagen in those with IR. The underproduction of
collagen as a consequence of IR and
explain in part CAWD in those
without t2d. For articles on collagen
and ascorbate click
on healthfully/rca.
k. Hypoxia and defective
mitochondria “Perturbations in the
regulation of glucose and lipid metabolism are both involved in the insulin
resistance in skeletal muscle in obesity and type 2 diabetes (2,3). Previously,
our
laboratory (30) as well as others
(31) have observed
that the
severity of skeletal muscle insulin resistance in type 2 diabetes and obesity
is related to diminished activity of oxidative enzymes. In addition, accumulation
of triglycerides in skeletal muscle is also correlated with the severity of
insulin resistance and with diminished oxidative enzyme activity in these
disorders.(23) . . . The mitochondria
area was reduce by ~35% in type 2 diabetes and obesity.” at 2002. Size and shape of
mitochondria are strong associated with compromised functioning of the mitochondria—see
for example the work of Nobel Laureate Otto Warburg. Research is needed to find
out if this change
also occurs with IR.
l.
Endothelial dysfunction and atherosclerosis and peripheral artery
disease “Endothelium plays a central role in atherogenesis” at 2002. “Endothelial dysfunction plays a key role in the
pathogenesis of diabetic vascular disease” at 2009. “Therefore, we
hypothesized that uric acid induces endothelial dysfunction by inhibiting
nitric oxide production” at 2005. Another contributory
factor is that following
apoptosis the “regenerated endothelial cells are dysfunctional”, at 2009, which parallels
the dysfunctional replacement collagen discussed IV I & j. The synergistic effects of excessive
fructosylation, under-production of collagen, and hyperuricemia and the
others mentioned in this section, they compromise the gatekeeper functions of
the endothelial cells lining the arteries in ways that promote
atherogenesis—see jk, and for a 2016 summation of endothelial dysfunction.
You need to put
out of your mind the industry causes of
saturated fats, cholesterol and hyperglycemia, and replace them with the
afore-listed consequences of the high fructose diet.
V. Diabetes a window on
causes of CAWD
a. Introduction: T2d is
quite different than type 1 diabetes(t1d).
T1d
is caused by the destruction of most of the insulin producing bête cells; t2d
is the result of IR that causes the excessive
accumulation of fat in the pancreas which causes underproduction of insulin.
Type 1 causes a pathological accumulation of
glucose which in the era before insulin was fatal in over 90% of the cases,
while type result merely in elevated glucose, a condition that often is not
significantly symptomatic. This period
of lowered production of insulin is altered by many of the drugs given to lower
serum glucose most often though elevating insulin.[18] The pathological association with t2d is complicated by the effects of
having for years elevated glucose and from elevated insulin (IR) and all the
effects listed about IR.
Many of these with t2d are
diagnose as having MeS, and thus
many have been taking for years statins and hypertension drugs. Once diagnosed
as diabetic, to the mix is add
the side effects from the medications that lower level of glucose. Of course
the doctors will attribute all the
side effects from being diabetic; pharma’s mantra is safe and effective. And it gets worse among the hypertension
drugs are those which effect cognitive functions, as does statins which lower ATP
40%. Being in a mental cloud creates reliance upon
their physician. Using LSPs as
a standard, 95% of those above
the age of 40 in the US population are IR.
Thus we have a complex system of causes at
work in which more research is needed to sort out the causal processes and
their degrees. I will assume that though
the literature associates the 4 below (and other not listed) as a result of t2d,
I will presume that in a
significant degree they are also present with IR.
With more research the
list will change. For now I will start
with biological difference that are associated with t2d, that have not been investigated
or the literature is thin to
see if it occurs with IR.
b.
NADPH depletion: There are other ways in which diabetes
(and I would aver IR) have
pathogenic consequences by reducing NADPH used in other metabolic processes to
the inactive NADP+. “Increased polyol
pathway activity also alters the redox state of
the pyridine nucleotides NADP+ and NAD+, thus reducing their concentrations.
Since these are important factors in many enzyme-catalysed reactions, many
other metabolic pathways may be also affected”
Science
Direct. The depletion of
NADPH oxidase is associated is caused by fructose and its causing the
production of ROS, 2004. “NADPH is also the essential cofactor for
regenerating a critical intracellular antioxidant, reduced glutathione”
Diabetes 2005. By reducing the amount of reduced glutathione,
the polyol pathway increases susceptibility to intracellular oxidative stress,
compounded by other biological consequences. High blood glucose elevates the production
of sorbitol and thereby can significantly reduce the level NADH; however, more
research is needed to show this potential issue has in fact pathological
consequences, and the significant tor a real-world population on the western
diet.
c. Lower
NO (nitric oxide) causes endothelial dysfunction: There a number of articles supporting lower
NO to causal for CVD through the
endothelial cells. The causal pathway is
through elevated glucose: “in vitro
with high concentrations of glucose activates protein kinase C (PKC) and
increases nitric oxide synthase (NOS III) gene expression as well as superoxide
production” Circulation Research
2011.[19]
I haven’t sufficiently
research this theory; nevertheless I
have a gut feeling that this isn’t a major cause or it’s a sign, like elevated
triglycerides rather than a cause. This
gut reaction is based on its putative connection with hyperglycemia others offer
an explanation based upon the lipid hypothesis
and hypertension
hypotheses,
neither of them are causes. Association
doesn’t prove cause. The NO-endothelial
dysfunction hypothesis fits into marketing goals of pharma. Over and over again
I have come across
pharma’s KOLs and others gathering evidence to support a pro-drug explanation;
but upon examination of the totality
of evidence I almost always reject the industry favored analysis and side with the
chorus of critical professors--sometimes the chorus is quite small. The chorus
is small for NO, but it seems to me that the reduced arterial dilation is a
sign of damaged endothelial cell rather than a cause of the damage. Even if
I am wrong, the roll of NO is less
than the major factors I stress. I consider both NO and the microbiome examples
of deliberate misdirection by industries.
d.
Microbiome:
It is
known that the microbiome has a role in diabetes pathophysiology”, Science May 2018, [20]
Seems farfetched for two reasons, one there is a known healing process which is
turned on when insulin is low, autophagy, and second the theory supposes that
the pathogenic bacteria are adversely effected by their reduction in glucose
supply more than the benign bacteria, and that in this weakened state the
benign bacteria will eliminate colonies of the t2d causing bacteria. As stated
in the footnote this misses the role of fructose, fatty liver and
pancreas. Given the complexity of the
microbiome with millions of species and subspecies of bacterial, I don’t think
given the present research will produce answers. Moreover, this fails to explain
why LSP don’t
develop t2d.
Fasting is good, but not for
the microbiome, but because of autophagy, which permits the metabolism of the
excessive fat in the pancreas and liver. Fasting subsequent to bariatric
surgery explains why over 80% of diabetic are cured or greatly reduce their
medication within weeks
of the surgery—this occurs before significant weight loss.
e. Fructosylation: The third step is the end-product of the
polyol pathway, the conversion of sorbitol to fructose and the fructose bonds
to amino acids and other receptive molecules such as unsaturated fats. This
production of fructose occurs
significantly in the kidney, retina, and nerves. All these organs have been
shown to have
elevated fructosylation end products and elevated health issues among the
diabetics. In additions through the polyol pathway fructose is the end product
in cells, and these cells—but for the liver-cannot metabolize fructose; thereby
causing fructosylation at a high rate.
Given the general lack of awareness of this issue, many researchers
attribute the damage to proteins and polyunsaturated fats as the result of ROS,
and their testing doesn’t distinguish the two possibilities. Though there
is little research, the lack of
a metabolic pathway for fructose outside the liver and our high sugar diet
support its cellular role in CAWD.
f. Defective mitochondria:
Type 2 diabetics have defective mitochondria, at 2005, 2006. “A reduced
basal ADP-stimulated and maximal mitochondrial respiratory capacity underlies
the reduction in in vivo mitochondrial function, independent of mitochondrial
content. A reduced capacity at both the
level of the electron transport chain and phosphorylation system underlies this
impaired mitochondrial capacity”, at 2008, see 2010 for more systems. The
reduce capacity of mitochondria entails a
lower rate of metabolism of both fats and glucose. This lower rate of turnover
of glucose
entails higher level of glucose in cells and blood, which entails in the cell
resistance to transport into the cell-- which is increased insulin--and thus an
increase release of insulin by the pancreas into the blood. A studied compared
10 lean persons to 10
type-2 diabetic, and their insulin levels were nearly 5 fold higher and their
fasting glucose 63% higher for the diabetic at 2001 see Tables 1 &
2 below. The cause for the reduction in
metabolism of glucose is that the mitochondria of type-2 diabetics are about
1/4th the size of a lean person This results in reduced ATP
production, and since ATP is the energy source for about 90% of synthesis
processes, this reduction has numerous negative cellular consequences. With
lower production of ATP the over 50
processes that promote cellular healing are down-regulated, and thus the
increased damage by ROS—see 2008, 2012[21], and 2011.
On top of
this insulin when low turns on those process (many of which are in the healing category
of
autophagy), thus IR reduces
the window of time for those healing processes.
The deformed mitochondrion, because of their lower production of ATP, is
a major cause for CAWD. I believe
that many of the lean like
those of the LSP are at very low risk for CAWD
in part because both have normal mitochondria. By extension given the diabetics
and normal
weight people on the western diet get the same conditions, only the diabetics
at several fold the rate, I propose that
many in the former to groups have smaller mitochondria but to a lesser
extent than the diabetics. Reduction in
ATP I hold is more significant that ROS, since ATP is essential for cellular
repair of non-enzymatic oxidation. Research
is needed to confirm what appears logical.
Table
2 from
2001![Description: TABLE 2 Electron microscopy measurements of mitochondria size in vastus lateralis skeletal muscle from lean and obese nondiabetic volunteers and type 2 diabetic subjects](data:image/png;base64,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)
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
Table 1 from
2001![Description: TABLE 1 Clinical characteristics of research volunteers](data:image/png;base64,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)
Tables from Dysfunction of Mitochondria in Human
Skeletal Muscle in type 2 diabetics, at 2002
g. “ Hyperosmolar hyperglycemic
state (HHS) is a complication
of diabetes mellitus in which high blood sugar results in
high osmotic concentration without
significant ketoacidosis.[4] Symptoms include signs of dehydration, weakness, legs cramps, trouble seeing, and
an altered level of
consciousness.[2] Onset is typically over days to
weeks.[3] Complications may include seizures, disseminated
intravascular coagulopathy, mesenteric artery occlusion, or rhabdomyolysis[2]” Wiki.
This tights in with
the above material on the polyol pathway as nature’s way of lowering increased
cellular osmic pressure caused by excessive cellular glucose. “ Triggers
include medications and combinations of medications, infections, trauma, and
major stroke or heart attack. Diagnosis
is based on blood tests finding a
blood sugar greater than 30 mmol/L (600 mg/dL), osmolarity greater
than 320 mm/kg, and a pH above 7.3.[2][3]
Older people are most commonly affected.[4] The risk of death among those
affected is about 15%.[4] It was first described in the 1880s[4]” Wiki.
Hyperosmolar thus
hyperglycemic state is only weakly associated with death once the confounding
variable of degree of IR is adjusted
for. Hyperglycemic state is greatly
over-emphasized by pharma. Tight
management of glucose doesn’t not for most types of drugs confir benefits for
patients. This conclusion is based on
the failure of studies to show that drugs which lower serum glucose while
raising cellular glucose lower mortality.[22] I couldn’t find a single study on diabetics
who aren’t treated, even though there a many who go years before diagnosis, and
other who manage their T2D with diet.
See Section VI for more on glucose.
g.
Uric acid role in pathology has been as much as the
research permits developed in Section II
f and Section IV b. The complexity
of its functions, the thinness
of research to the other conditions besides CVD and nephritis, and lack of a
seminal article putting it all
together are the reasons I am not again developing this topic.
h. Cortisol Is a steroid hormone produced by the zona
fasciulata of
the adrenal cortex. When used as a
medicine is it known as hydrocortisone.
It is elevated in
diabetics. After spending a week looking
at the evidence in support of elevated cortisol as a major cause of pathologies
weak. Its association with diabetic
complications is based upon the degree of diabetes Thus its elevation in diabetics
I hold to be a response to the conditions associated with IR, rather than a cause
of those conditions. In fact it might be, like with the immune
system, a response to stress.
“[C]ortisol secretion was found to be associated with complications and
metabolic control of diabetes, at 2007. And again I must suspect
that pharma has sullied the evidence base because of the use of off-patent
hydrocortisone.
i. mTOR
j. Summation:
I hold there is a continuum
of IR, with t2d being the most advanced
and pathogenic. Based on the continuum, the increased risk
for nearly all of the CAWD is part
of that continuum, and thus the finding for t2d can be extended to IR.
VI. Blaming elevated glucose for the
comorbidities of t2d, obesity, and MeS—association doesn’t prove significant causality but
profits industries
a.
Evolutionary
question: evolution does a very good job of protecting
mammals from common environmental hazards.
Why don’t LSP on a high starch diet have high fasting glucose and HbA1c?
And why don’t they have conditions associated
with the western diet in proportion to their serum glucose level? Their level
is below 95% of Swedes in 1999, see Section
1c, yet the conditions are
virtually unknown? These questions
suggest that dietary glucose e is not the problem, nor elevated serum glucose,
but rather recent dietary changes, in particular fructose.
The pattern repeats: Pharma profits from treating a sign and
searching for new drugs to treat signs while burying the major causes under a
stack of KOLs’ journal articles.
Managing glucose and the chronic conditions that develop is very profitable.
B . Glycation by glucose is not a major cause for
CVD and other CAWDs: This bromide of medical wisdom was
born out of t1d study, however, it
is much different condition than t2d:
one condition has near zero production of insulin, the t2d patients have
IR, insensitivity to insulin.
When their pancreas production of insulin declines (because of fat
accumulation), their IR becomes
mildly symptomatic. The response to
drugs that raise insulin or promote its activity are much different for these
patients.
Dr. Jason Fung points this out in the Obesity
Code, p. 80 that pharma used a trial for t1d the lower side effects,
to “educate” doctors with this trial
(and other subsequent trials); however, the logic is flawed because most t1d
patients were never insulin
resistant. And it gets worse in that
pharma ignored the weight gain of 9.8 pounds more for the tight control
group—insulin promotes fat storage. By
not following the long-term consequence, pharma avoids the side effects associated
with MeS including obesity including
cancer. This and in other ways they
produced results which supported the role of glucose as the major pathogenic
factor, and thus that diabetics both type 1 and 2 needed to tightly control the
level of glucose.
Several types
of evidence presented
here show that glucose alone is not pathogenic.
For example those life-long low-sugar diet high starch diet: traditional
Japanese diet which is high in
the refined carbohydrate white rice; they have a low rate of CAWD—and it
would have been lower if
they didn’t smoke and drink. So
too
does other societies such as Kitavans and Okinawans who eat starchy root
crops as a staple. All of them average
less than 30 grams of sugar daily from all sources. A high glucose/starch diet
doesn’t cause IR, t2d, MeS,
or CAWD. Thus the association of
the western diet
doesn’t prove causality for refined carbs--merely removing the nutritional
parts from grains is not causal.[23] As shown above it is the fructose mainly
obtained from sucrose that is causal.
Another consideration
is the lack of
linear association of CADW with the
increase in serum glucose: the normal level
of serum glucose for those on a western diet and the elevated level of
prediabetics. The diabetic is not
considered because their level is now similar to the prediebetic. START
c.
A
historical prospective: Gary Taubes in The Case Against Sugar
reviews the biological effects of fructose and how industry has deflected
criticism. Sugar came into the 20th
century with a bad rap, that of causing the health problems of the upper class,
since until about the 1850s only the affluent could afford those luxury
foods. Then with the extraction of sugar
from cane and beats the price dropped, but usage was for most of the working
class limited. The market for sugar
laden product grew but was still one third of our present consumption. Gout
and obesity were the most visible
conditions of the affluent, and it was popularly held to be caused by
sugar.
____________________________???
The difference is about 30%, but for most
conditions the risk is doubled or greater.
When that person drifts toward t2d, the period of elevation is typically
under a year, which is two short a period for the pathologies that
normally develop after 10 years and longer.
The biological evidence for cause of those conditions as being linked to
glucose is weak, made all the weaker when compared to the same type of evidence
for fructose. Thus elevation of the less
reactive glucose is insufficient to account for the increase in CAWD.
,??? this pales in comparison to the Kitavan
thus the pathological consequence I would place behind uric acid,
underproduction of collagen, and polyunsaturated fats (see below) on the list
of causal factors for CAWD. One reason
is based on results of tight management of glucose for type 1 and type 2
diabetics doesn’t have positive endpoint outcome.[24] Pharma holds diabetes is a lifelong progressive disease and
that their comorbidities are caused by
high plasma glucose through glycation and its subsequent oxidation (ROS), thus ideal treatment is to keep glucose low with
drugs. But rather then cut back on
drugs, carbohydrates are not restricted:
their KOLs including those in ADA (American Diabetic Association) hold
that eating carbs (glucose) is necessary to avoid hypoglycemia caused by their
drugs, and this should be done 6 times a day.
But clinical Trials have failed to show that tight management of glucose,
compared to standard treatment for diabetics reduces the elevated pathologies
associated with t2d. Glycation, as stated in II b, is the non-enzymatic attachment
of a monosaccharide to a protein (amino acid), and this both compromises both
the functions of the protein and through further reactions by ROS produces pathogenic
products. Again sadly I must mention the norm for
industry–funded studies is scientific fraud NEJM.
A second norm is for pharma to expand the market for their drugs. As
a consequence, doctors are told by KOLs
and given handout reprints of journal published clinical trials which
“demonstrate” that for t1d and t2d
tight management of blood glucose
results in lower adverse advents. “This
[UKPDS] reported three endpoints: it
found no benefit for the first two, which were dearth and diabetes-related
death; but it did report a 12 percent reduction in composite endpoint [of 14
items]” (Ben Goldacre, p 196). Other
studies have confirmed this. The Cochran Review meta-analysis found using industry studies that with
tight control compared to standard control, “treatment in 1,000 adults would
lead to between zero and two people avoiding non-fatal myocardial
infarctions”. And it gets worse, in that
with tight management the increase in drugs diabetes is accelerated and thus if
tracked until the endpoint of death, tight management significantly shortens
life and quality of life. Tolerance to
insulin results in a spiraling increase in insulin injections and with that
increased fat storage (weight gain), and the comorbidities of t2d; it is why
t2d is called a progressive
disease. The studies of
pre-diabetics--ADA criteria for fasting glucose 100 mg/dL to 125-- have failed
to justify the use of drugs even though the pre-diabetics have substantial
increased risk for all the CAWD
compared to those who se level is in the bottom 20%.
d. Fructose is safer than sugar for diabetic and
doesn’t cause MeS--Wikipedia: An expert panel of
the European Food Safety
Authority concluded that fructose is preferred
in food and
beverage manufacturing to replace sucrose and glucose due to the lower effect
of fructose on blood glucose levels following a meal.[11] However, as a
common sweetening agent for foods and beverages, fructose has been associated
with increased risk of obesity, diabetes, and cardiovascular disorders that are
part of metabolic syndrome.[9] Clinical research has provided
no or only limited direct evidence that fructose itself is associated with
elevated LDL cholesterol and triglycerides leading to
metabolic syndrome,[53] but rather
indicates that excessive consumption of sugar-sweetened foods and beverages,
and the concurrent increase in calorie intake, underlies metabolic syndrome.[9] Similarly, increased consumption
of
sweetened foods and beverages raises risk of cardiovascular disease,
including hypertension,[54][55] but there is
no direct cause and effect relationship in
humans showing that fructose is the causative factor.[9]
Fructose is often recommended for
diabetics because it does not trigger the production of insulin by
pancreatic β
cells, probably
because β cells have low
levels of GLUT5,[56][57][58] For
a 50 gram reference amount,
fructose has a glycemic
index of
23, compared with 100 for
glucose and 60 for sucrose.[59] Fructose
is also 73% sweeter than
sucrose at room
temperature, allowing diabetics to use less of it per serving. Fructose
consumed before a meal may reduce the glycemic response of the meal.[60] Fructose-sweetened
food and
beverage products cause less of a rise in blood glucose levels than do those
manufactured with sucrose or glucose.[11]‑ Wiki 2018, June. This is another case of industry’s
experts
writing the articles and framing the topic for dieticians, physicians, and
media--welcome to United States Inc.
VII
Prevention and signs
of insulin resistance
a. Prevention: Prevention is easy simply limit sugar. How much depends on metabolism. An elite athlete can consume
about 4 times
the average 70-year old without developing insulin resistance. For a person
who isn’t IR the average male, active 30-year old can consume can consume
about 60 grams a day, and a woman about 40 grams. Teens can consume more. Activity level and rate of metabolism make a
big difference. But why endure the fate
of Prometheus?[25]
damage the liver with fructose and then have it repaired Of course the best
diet is to stay low fructose.[26]
b. How to tell if you are insulin resistant: A person who is insulin resistant can have
normal HbA1c and normal fasting glucose because they are secreting excessive insulin
to lower blood glucose. Only in more
advanced state of IR dose that
person have a rise in both of the glucose measurements. The gold standard is
to perform a glucose
tolerance test in which insulin is measured, not the serum glucose. See below
the Joseph R. Kraft section; he
performed this test on over 14,000 patients.
Other signs strongly associated with IR are 1) a fatty liver (NAFLD)
for which a sonogram is the preferred test; 2) elevated HbA1c and/or fasting
glucose; 3) to gain weight and need to diet to lose it; 4) yo-yo diets; 5) a non-smoker
who has atherosclerosis thus CVD; 6)
hypertension, which is a sign of atherosclerosis and kidney damage; 7);
elevated uric acid which is causal for kidney damage and ED; 8) and CAWD—see Section
I.
Given that when compared to the Kitavans who eat a high starch diet
which is low in sugar, by their standards about 90% of adults by the age of 30
are insulin resistant—see Staffan Lindeberg, are the work of Joseph Kraft in
appendix.
VIII The error of blaming palmitic acid
or other saturated fats
for CVD
“Since the 1990s, these
researchers have established certain
findings unambiguously. First, feed
animals enough pure fructose or enough sugar (glucose and fructose) and their
liver converts some of the fructose into fat—the saturated fat palmitic acid,
to be precise, which is the one that supposedly
gives us heart disease when we eat it, by raising LDL cholesterol [see
cholesterol myth]. The biochemical pathways involved are clear
and not particularly controversial. Feed
animals enough fructose for long enough and this fat accumulates in the liver,
cause the kind of fatty liver seen in obese children and adults. The fat accumulation
accompanies insulin
resistance, first in the liver and then other cells as well, resulting in
metabolic syndrome, at least in laboratory animals. . . . The effects may take
several months to
appear if the animal are fed something closer to what humans in America
actually consumer—around 20 percent of calories in their diet. Stop feeding
them the sugar and the fatty
liver goes away and with it insulin resistance . In a 2011 study in which twenty-nine
rhesus
monkeys were given the opportunity to drink a fructose-sweetened beverage along
with their unusual monkey chow, every last one of them developed “insulin
resistance and many features of the metabolic syndrome” within a year, and four
had progressed to type 2 diabetes”--Taubes, p204-5. De novo lipogenesis produces palmitic
acid[27]. The association with CVD is through the fructose which is converted to palmitic acid,
thus it is the fructose that is causing CVD.
This is one way that palmitic acid and in
general saturated fats get blame form CVD
and ischemic events. The fire caused by
the high starch plus fructose in the liver is ignored while the blamed is
placed upon their conversion product palmitic acid.
XI
Dietary
fix
insulin resistance, type-2 diabetes, obesity, fatty liver, TOFI,
and CAWD
a. What doesn’t work: eat less and move more Pharma’s and food manufacturer’s fix is to
eat less, exercise more, frequent small portions, and replace energy dense fats
with carbs; thus a high insulin diet. It
work for those who don’t have long-term (over 2 years) weight issue, because by
the end of 2 years most with the exception of some children, have had their
weight regulatory system rest through the hormones secreted by the adipose
tissue to the increased weight. The
standard advice doesn’t fix the
mammalian weight-regulatory system because it doesn’t cure IR; thus, we
have the yo-yo diets.
Yo-yo because—as mentioned above—leptin secreted by the adipose tissue
functions to restore the amount of fat to a set point, and in this case because
of insulin resistance, that point has been set in their recent past. Leptin
then will cause an increase in
appetite and a reduction in metabolism of 20—40%; and with that reduction the
dieter will fell that he needs to eat more to feel better. This is why for most
gradually over the next
6 years their weight increases to the set point and frequently higher if that
person is sufficient insulin resistant; this is the fate of nearly all those
who attempt to restore their health by the caloric-restricted diet recommended
by physicians.
b.
Obesity and t2d are
dietary problems with a dietary fix.
The path to health is illuminated by the results of bariatric
surgery. Bariatric surgery is able to cure 80% of
the diabetics, and 51%
at 12 year follow
up. Most diabetics
following the surgery are off their medication in the first two months, before
major weight loss. Following surgery the
intravenous feeding limits calories to around 500 per day; this indicates that
the forced fasting is curative vector—not weight loss. Other
studies have shown that fasting
and for some the ketogenic diet
cures through metabolism of excess stored fat in the liver, and for diabetics
in the pancreas. Following surgery they
are on an extremely low calorie, low insulin diet; their body metabolizes the
excess fat in the liver and pancreas which cures their diabetes and insulin resistance—excess
insulin increases fat storage.[28] The long-term cure rate would be higher if
those surgery patients had been warned of the roll of fructose and had a low
carb diet in the hospital and afterwards.
A small but growing group of physicians (Dr. Jason
Fung and Dr. Michael
Mosley[29] are the
best known) are now advocating fasting (both intermittent and alternate day)
and lowing carbs or a ketogenic diet.
They have been able to cure type-2 diabetes and obesity by curing
insulin resistance and fat storage in the liver and pancreas. With low insulin,
the body continues the
process of autophagy—started while sleeping—that metabolizes the excess fat in
the pancreas which causes the reduction in the production of insulin for those
with t2d. The metabolism of the excess
fat in the liver cures NAFLD and IR. Since
insulin causes fat storage, the low
insulin diet accelerates weight loss.
Mediterranean
diet is healthy
because of the high consumption of olive oil; wrong, it is the low consumption
of sugar. This is part of the mountains
of proposed causes and fixes currently circulating. That which explains what
has gone wrong and
the fixes are buried within the mountain of media stimulated social
twaddle. Switching to a Mediterranean
diet won’t fix the fatty liver, insulin resistance, and diabetes, thus what is
offered as a fix, isn’t: nor will it cure IR,
because of the failure to warn about sugar.
Good and
bad fats: “The type of fats in the diet are important, with saturated fats and trans fatty acids increasing the
risk, and polyunsaturated and monounsaturated fat decreasing the risk[26]” Wikipedia (contrary to the mass of evidence, see rancid fats and saturated fats). The only way to sort out the tobacco science is to
question everything, and rely upon the modus operandi. The modus operandi: Polyunsaturated and to a lesser extent
monounsaturated fats because of their double bond(s) have free electrons which
is available for attachment to by reactive chemicals, which when in sufficient
amounts and occurring within cell walls, it becomes a healthy issue. Because
of oxidation, milk is high in
saturated fats.
The Dietary
Fix and in concise, some
links: The question isn’t how can I
lower my risk factor for CAWD to
that of those who live on Crete (Mediterranean diet),[30]
but to lower it to the level of the Kitavans (footnote 11). This requires undoing
the damage done to our
complex weight regulatory system, and then not damaging it again by excessive
fructose.[31] The simple answer is fasting made more
effective with a low carb diet. To
learn more I highly recommend reading
the two books by Dr.
Jason Fung and watching his lectures
on
YouTube. In a more concise
form then his books, you will find my dietary
advice and a longer
version (my advice
was arrived at prior to reading and watching his lectures). It is easier
not
to eat than to significantly
reduce calories long term. With fasting the body burns fats, not
conserve it, and increases metabolism to promote searching for foods. It
is as Dr. Fung wrote in Obesity
Code, “It is more important not to eat than what you eat.” In
one clinical trial, skipping breakfast
resulted in a reduction of 539 calories per day. An easy start is intermittent
fasting
(skipping a meal or 2) and progress into alternat e day fasting and thereby avoid
the metabolic consequences of being in the starvation mode. Going on a
low carb (insulin) extends
autophagy and accelerates the rate of weight loss.
[1]
Refined carbs/glucose alone is not enough to cause metabolic syndrome. A number
of primitive societies have a diet
high in easily digestible carbohydrates, such as the Polynesians. Traditionally
the Japanese and Chinese
consumed up to 70% of calories in the form of white rice and noodles, yet they
those who did don’t develop metabolic syndrome, not until sugar was
introduced. The Japanese for example
consumed 14 grams of day of sugar, mainly from vegetables. Refined carbs, gluten,
GMOs, chemicals, fats,
cholesterol, lifestyle, stress are examples of a misleading half-truth: a way
of causing cognitive dissonance
(confusion & inaction).
[2] An
intere sting historical fact is that Sir Richard Doll whose seminal works in
the 1950s linked cigarettes to lung cancer, he wrote the introduction to Diabetes,
Coronary Thrombosis and the Saccharine Disease by Campbell and Cleaves
the leading authorities on the health of aboriginal peoples, They linked CAWD
to sugar. See also Taubes Good Calories Bad Calories, p.
112.
[3]
The best book on their lack of western diseases is Western
Diseases: their emergence and prevention, 1981, Trowell and
Burkitt.
[4]
Ingestion of proteins as amino acids in the blood stimulate the release of
insulin.
[5]
Authored by Robert Lustig, Maryanne Demasi and Aseem Malhortra (from US,
Australia, and UK), they are part of the wave of critics based on sound science
that opposes pharma’s lipid-cholesterol hypotheses, which includes among other
things holds that a diet high in saturated fats promotes type-2 diabetes at
2017.
[6]
This also could explain why in the veins atheromas do not form, but when placed
in the coronary artery over half of them become atherosclerotic, often within 2
years. The rate of blood flow promotes
abrasive damage to the transplanted veins.
[7] “Although fluorescence
measurements showed that
fructose causes far more protein damage than glucose, neither serum fructosamine
(SFA) nor phenylboronate affinity (PBA) glycation assays reflected these
changes. The SFA method implied that fructose causes only about 5% of the
glycation induced by glucose; with PBA the proportion was 25%. The
thiobarbituric acid- and periodate-based assays also greatly underestimated the
true extent of fructation” 1992.
. My recent search of the literature came to the
same conclusion of under-estimating.
[8] For
diabetics on benefit of niacin and a personal note, I have since about 1977
been taking supplement of vitamin B3, niacin, in the form of nutritional yeast
averaging about half an ounce a day.
“These results clearly highlight the
antiglycation activity [protecting HAS] of niacin
and its potential in preventing disease progression in diabetes” at August 2017.
[9] “Endol form”,
refers
to the change in structure between an alcohol and a ketone and back again that
occurs under specified conditions. This
shit between two forms occurs at a rate 300 times that of glucose because
fructose exists in a 5 member ring that and glucose forms the more stable 6
member ring. “{F]ructose is produced in
the polyol pathway… comparing fructose to glucose in the effects on glycation,
fructose … reduced digestibility of collagen by collagenase from 86% to 15.9%”…
suggesting the marked effects of fructose on production of AGEs…. As a reducing
sugar fructose has 300 times as many reactive chain structures as glucose (16)”
(at 132-133).
[10] Aldose reductase are enzymes that serve to
protect tissues from too much glucose. “Aldose
reductase is an enzyme present in lens and brain that gets rid of excess glucose by converting it to sorbitol” Wiki. “These observations support the hypothesis that
increased
metabolism of glucose via the sorbitol
pathway is of central importance in mediating virtually all of the early
changes in vascular filtration function associated with diabetes in the kidney,
as well as in the eyes, nerves and aorta” see
1990. However,
the protection system will malfunction in those who are insulin resistant
through the accumulation of sorbitol and fructose, and thus pharma attempted to
develop a class of drugs to shut down the production of sorbitol and fructose,
but the net benefit was lacking. NOTE:
The examination of the aorta is an indication that IR & diabetes are
atherogenic conditions. A second safety valve for glucose caused osmotic
pressure is through the urine (polyuria), which occurs among those with t1d—see
Wiki. The whole link
of fructose feeding, excess
glucose, polyol, and kidney damage: “It is concluded that
prolonged fructose feeding
results in the accumulation of sorbitol in the kidney, caused by increased flux
of glucose through the polyol pathway” at 1987.
[11]
Though not within the scope of this paper, there is extensive speculation as to
why many species of apes can’t synthesize ascorbate, yet most mammals, and
other higher orders do. For example, “Goats, like many animals but not
humans, make their own vitamin C. An adult goat, weighing approx. 70 kg,
will manufacture more than 13,000 mg of vitamin C per day in normal health,
and levels many-fold higher when faced with stress.[75] Wiki. This
might be particular significant in making humans susceptible to the high sugar
diet through fructosylation and ROS and other ways while vitamin C making
mammals who are on a high-sugar and high-carb diet are protected NOTE:
Since murine species make vitamin C, they are not a suitable model for
the pathologies associated with
[12] “Evidence has accumulated indicating that
the generation of reactive oxygen species (oxidative stress) may play an
important role in the etiology of diabetic complications. This hypothesis is
supported by evidence that many biochemical pathways strictly associated with
hyperglycemia (glucose autoxidation, polyol pathway, prostanoid synthesis
[prostaglandins, thromboxanes, and prostacyclins], protein glycation) can
increase the production of free radicals” at 1996.
[13] “Excess intracellular polyol
concentration can lead to an osmotic imbalance, causing excessive cellular
water. The resulting cellular disruption
is known, or is suggested, to be responsible for a number of pathological
conditions in various tissues, such as cataracts in the lens and neuropathy in
peripheral nerves (for review see Winegrad et al., 1972).” click on link to. Full version 1983.
[14]
In the study they used the other common reactive sugar galactose. The aldose
reductase inhibitor sorbinil was
fed a cohort which had “markedly
reduced or completely prevented
all of those changes galactose fed, as well as diabetic rats,” This
was accomplished through ”a ten-fold
increased urinary excretion of endogenous albumin and IgG” .
[15] “It is c oncluded that prolonged fructose
feeding results in the accumulation of sorbitol in the kidney, caused by
increased flux of glucose through the polyol pathway” at 1987.
Sorbitol is a substrate in the production of collagen, and ascorbate an
essential co-enzyme. “Ascorbate may
prevent complication with underlying collagen abnormalities’ Diabetes
1988, and same 1989,
[16] “These three reactions are catalyzed by very
large, multi-subunit enzymes prolyl
4-hydroxylase, prolyl
3-hydroxylase and lysyl
5-hydroxylase, respectively.
These reactions require iron (as well as molecular oxygen and α-ketoglutarate) to carry out the
oxidation, and use ascorbic
acid (vitamin C) to return the iron to its
oxidized state. Deprivation of ascorbate leads to deficiencies in proline
hydroxylation, which leads to less stable collagen, which can manifest itself
as the disease scurvy” Wiki..
[17] “Collagen decreased
to 49% in mildly diabetic rats
and 16% in severely diabetic rats, compared with control rats fed ad libitum
and decreased to 85 and 73%, respectively, in food-restricted rats (both P <
.01 vs. diabetes)” June 89 Diabetes.
[18] I do not
know of studies on patients who refuse treatment and live with the elevated
glucose and low insulin. If done in the interest of science with the important
issues examined, the study would shed some light on the effects of long-term
elevated glucose..
[19]
This study is further suspect because rats do not form a model for human
diabetes. Unlike humans rats manufacture
ascorbate, thus inducing t2d among
rats can’t be shown to be dispositive unless it can be shown that the
pathological consequences with low ascorbate and normal would be the
same—assuming that would still leave open the possibility of rats still being a
poor model.
[20]
This article rather than acknowledging the role of fatty liver and fatty
pancreas as the explanation for the ability of fasting to cure t2d aver that
“In contrast to chronic caloric
restriction, intermittent fasting limits food intake to certain hours of the
day, which is believed to benefit metabolic outcomes with relevance to diabetes,”
supra.
[21] Key points include Acquired
insulin
resistance is associated with reduced insulin-stimulated mitochondrial
plasticity that results in the inability of the organism to switch from fatty
acid to glucose oxidation in skeletal muscle
[22] Dr Jason Fung develops the topic
of
medications that lower glucose: “Yet
again, the glucotoxicity paradigm was proved inadequate to explain what was
happening. Clinical benefits only accrue
when both glucotoxicity and insulin toxicity are reduce, Obesity Code, p
148--for full development of topic see Chapter 11.
[23]
Importance detail is that glucose in cells is metabolized first, thus in a
chart I saw the area under the graph indicates that fructose has twice the area
for glucose under the graph for equal amounts of both, thus doubling fructose
potential for damage.
[24]
Given the concern over glucose figures and the over 25% of seniors have t2d,
the practice of intensive control
does more harm than good, and even more so in the younger population of
diabetics. The Des Spence BMJ article vents
some of the issues.
[25]
Prometheus is a Titan that had the ability to see the future. As punishment
for not revealing how Zeus
would be overthrown, Zeus had the Titan chained to a rock and every day an
eagal would eat out the Titan’s liver.
It would grow back during the night.
For a dramatic account watch
Aeschylus’s Prometheus Bound and closer to the original
performance.
[26]
Galactose is the other reactive sugar, and it too is metabolized mainly in the
liver. However, unlike fructose whose
metabolism is delayed by glucose metabolism, galactose is metabolized to
glucose rapidly in the Leloir pathway.
Thus a young infant has about 40% of it calories from lactose, yet
doesn’t develop fatty liver or insulin resistance. See Disorders
of Carbohydrate Metabolism, 13,
[27] “Hepatic de
novo lipogenesis and TG secretion. The DNL process begins with
the conversion of acetyl-CoA into malonyl-CoA by ACC. Malonyl-CoA is condensed
with several acetyl-CoA moieties by FASN to produce a 16-carbon palmitic
acyl-CoA…. De novo fatty
acids. The saturated fatty acid
palmitic acid is the main product of fatty acid synthase. Long-chain elongase
(LCE) can extend palmitic acid by 2-carbons to generate stearic acid. Palmitic
and stearic acids serve as precursors for palmitoleic and oleic fatty acids
respectively, where a double bond is incorporated into the fatty acid chain by
sterol-CoA desaturase (SCD)” Lipid
health
Dis 2016.
Without
the sugar, there wouldn’t be production of palmitic acid in the liver—as proven
by LSP consuming mostly fats.
[28]
Prior to bariatric surgery the effective treatment for the morbidly obese was
prolonged water fasting with some electrolytes and vitamins (no
protein)—apoptosis of adipocytes provides amino acids. Fasts typical ran
about 100 days, the record is 382 days.
[29]
Dr. Mosley, a BBC documentary producer, wrote in 2015, The 8-Week Blood Sugar Diet: How to beat diabetes fast (and Stay off
medications--#1 international bestseller. Links for their documentaries
and books are
provided in this web section.
[30]
If the Mediterranean diet was very low in sugar like the traditional Oriental
the risks would be much lower.
[31]
This happens to about half of those who have bariatric surgery, which cures
about 80% of those with type-2 diabetes so that they are off their
medications. The food restriction allows
the body to metabolize the excess pancreatic fat that causes their diabetes. However,
the distains and physicians not
knowing the cause, give bad advice with its unfortunate consequences.
This is continued at the next page
What can the 1,300 pound gorilla do, pretty much anything it want--prof. Marcia
Angell, Harvard
DISCLAIMER: As Ben Franklin said, we all keep our own time; thus
what I write is what I believe & thus would do; however, I am
not recommending others to violate clinical guidelines or their doctors’
recommendations
|
|
|
![](/imagelib/sitebuilder/layout/spacer.gif) |
![](/imagelib/sitebuilder/layout/spacer.gif) |
|